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Jennifer Wright-Berryman 
The Influence of Decision-making Preferences on Medication Adherence for Persons 
with Severe Mental Illness in Primary Health Care. 
People with severe mental illness (SMI) often suffer from comorbid physical 
conditions that result in chronic morbidity and early mortality.  Physical health decision-
making is one area that has been largely unexplored with the SMI population.  This study 
aimed to identify what factors contribute to the physical healthcare decision-making 
autonomy preferences of persons with SMI, and to identify the impact of these autonomy 
preferences on medication adherence. 
Ninety-five adults with SMI were recruited from an integrated care clinic located 
in a community mental health center.  Fifty-six completed a three-month follow-up.  
Multiple linear regression for hypothesis 1 (n=95) and hierarchical regression for 
hypothesis 2 (n=56) were used to analyze data on personal characteristics, physical health 
decision-making autonomy preferences and medication adherence.  For the open-ended 
questions, thematic analysis was used to uncover facilitators and barriers to medication 
adherence.   
With this sample, being male predicted greater desired autonomy, and having less 
social support predicted less desired autonomy.  When background characteristics were 
held constant, autonomy preferences and perceived autonomy support from the physician 
only contributed an additional 1% of the variance in medication adherence.  Lastly, 
participants reported behavioral factors and having family/personal support to take 
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medications as facilitators to medication adherence for physical health care, while citing 
financial and other resource limitations as barriers. 
  Hea-Won Kim, Ph.D., Chair 
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Chapter 1: INTRODUCTION 
Prevalence and Definitions 
Mental health disorders account for four of the ten leading causes of disability in the 
U.S. (NIMH, 2001), and severe mental illnesses such as schizophrenia, bipolar disorder, 
and major depression are found in approximately 5% of the U.S. population (McGrath, 
Saha, Chant, & Welham, 2008).  Severe mental illness (SMI) is defined by the United 
States Department of Health and Human Services, Substance Abuse and Mental Health 
Services Administration (SAMHSA) as:  
 A mental, behavioral or emotional disorder (excluding developmental 
and substance abuse disorders) 
 Diagnosable currently or within the last year 
 Of sufficient duration to meet diagnostic criteria specified within the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
 Resulting in serious functional impairment, which substantially 
interferes with or limits one or more major life activities (SAMHSA, 
2008B) 
 Various terms are used to describe a person in mental health treatment, including 
“patient,” “client,” and “consumer”.  This list of terms is not exhaustive, but 
representative of language used in medical/treatment settings.  For this study, the term 
“patient” will be used when referring to a medical setting, and the term “consumer” will 
be used when referring to a mental health treatment setting.  In all other cases, 
“person(s)” or “people” with mental illness will be used. 
The Morbidity and Mortality Crisis 
 People with severe mental illnesses often have comorbid physical conditions that 
contribute to morbidity and mortality rates that are higher than the general population.  In 
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2006, the National Association of State Mental Health Program Directors (NASMHPD) 
published a technical report providing a comprehensive look at the morbidity and 
mortality crisis for people with SMI (NASMHPD, 2006).  This report contained a 
sixteen-state study on mental health performance measures, including mortality data from 
eight states (Lutterman, 2003), plus morbidity and mortality studies from Maine, Ohio, 
and Massachusetts.  Overall, people with SMI died approximately 25 years earlier than 
the general population, and approximately 10 years earlier than those with non-severe 
mental illnesses, such as milder forms of depression and anxiety (Lutterman, 2003).  In 
Massachusetts, persons between the ages of 25-44 served by the state public mental 
health system were 6.6 times more likely to die younger from cardiovascular disease than 
those in the general population (Freeman, 2006).  In Ohio, heart disease was the leading 
cause of death for the SMI sample, with an average age of death at 51 years, amounting 
to 27 years of potential life lost (B. J. Miller, Paschall, & Svendsen, 2006).   
 Numerous studies provide further insight into the nature of the morbidity crisis.  
In general, a majority of persons with SMI are found to have one or more physical health 
comorbidities, and half of those persons have two or more concurrent physical health 
diagnoses (Jones et al., 2004).  Sokal et al. (2004) compared physical health data of a 
group with schizophrenia and a group with depression and matched controls from the 
general population.  They found that compared to the matched controls, the group with 
schizophrenia was more than twice as likely to suffer from asthma, more than three times 
as likely to have chronic bronchitis, and were nine times more likely to have emphysema.  
The group with depression was also twice as likely to have asthma, and four times more 
likely to have chronic bronchitis and emphysema than the control group.  Additionally, 
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the group with depression also had increased odds of rheumatoid arthritis and stroke.  
Both groups had increased rates of diabetes, but the group with depressive disorders had 
a higher rate than the group with schizophrenia. 
 Researchers have identified several contributing factors to this morbidity and 
mortality crisis.  Many of these factors are associated with a metabolic syndrome that 
occurs from taking atypical antipsychotic medications for long periods of time.  Deakin et 
al. (2010) describe the metabolic syndrome as a group of risk factors (such as weight 
gain, hypertension and insulin resistance) that occur together to increase the risk for 
cardiovascular disease, type II diabetes, and stroke.  Although metabolic syndrome has 
been attributed to weight gain and subsequent insulin resistance as a result of taking 
atypical antipsychotics, the exact causes of the syndrome are not fully understood (De 
Hert, Schreurs, Vancampfort, & Van Winkel, 2009). Casey et al. (2004) reported that 
people  with schizophrenia using antipsychotics such as olanzapine and clozapine were 
six times as likely to have insulin resistance compared to the group using conventional 
antipsychotics.   In another study by Cohn et al. (2004), men with schizophrenia were at 
greater risk than women with schizophrenia for coronary heart disease, but both groups 
were twice as likely to have metabolic syndrome when compared to the general 
population.  Additionally, metabolic syndrome occurs at a younger age in the population 
with schizophrenia and seems to occur in older age versus the general population.  In the 
reference group, the rate increased more linearly with age (Cohn, 2004). Therefore, 
increased risk starts earlier and lasts longer in the schizophrenia group. 
Obesity in this population, another risk factor associated with metabolic syndrome, 
is related to both psychotropic medications and sedentary lifestyle.  A study comparing a 
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group with SMI with a geographically-matched group in the general population found 
that significantly more of the SMI group was obese: 50% of females and 40% of males, 
versus 27% of the females and 20% of males in the matched comparison group 
(Dickerson et al., 2006).  Research has uncovered that people with SMI eat a diet that is 
higher in fat, lower in fiber and nutritional foods, and get less exercise than those in the 
general population (S. Brown, Birtwistle, Roe, & Thompson, 1999).  Poor choice in self-
care is only one explanation for these habits.  Another explanation is that living in 
poverty restricts the ability for those with SMI to obtain nutritional foods and exercise 
opportunities (Newcomer, 2007).  Obesity has become a national healthcare agenda, not 
just for people with mental health issues, but for the general population.  Recently, the 
Center for Medicaid and Medicare Services announced a plan to provide Medicare 
coverage for intensive obesity counseling, and it is expected that over 30% of Medicare 
recipients will be eligible for the benefit (CMS, 2011). 
Another major concern about the lifestyle of people with SMI is the high rate of 
smoking, which is more than twice that of the general population (Lasser et al., 2000), as 
approximately three-quarters of people with SMI smoke cigarettes.  Smoking has been 
shown to improve the neurocognitive processes in schizophrenia, including recognition 
and attention (Quisenaerts et al., 2013).  The rate is even higher among those who have a 
comorbid substance abuse disorder, almost five times that of the general population 
(Ferron et al., 2011).  The relationship between smoking and disease has been widely 
studied in the medical and epidemiological literature, and it has been concluded that 
smoking leads to a higher risk for cardiovascular disease (Bowden, Miller, & Hiller, 
2011) and cancer (Howard et al., 2010).  Cardiovascular disease remains the leading 
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cause of death in the United States, and is also the leading cause of death among the SMI 
population (Newcomer & Hennekens, 2007).  Cancer seems to be less of a problem, but 
this may be because the life expectancy of people with SMI is often too short to be able 
to adequately determine cancer prevalence and incidence (Howard et al., 2010). 
According to Lambert, Velakoulis, and Pantelis (2003), limited access to adequate 
physical healthcare,  poor treatment adherence, and general neglect of physical needs are 
also reasons why people with SMI have more comorbid illnesses.  One explanation could 
be the lack of resources that people have to afford care (DiNitto, 2012).  Additionally, 
some patients with SMI have difficulty expressing or describing their physical symptoms, 
and understanding the treatment directions given by the physician to make lifestyle or 
other changes at home.  People with SMI may encounter system barriers that complicate 
taking care of their physical health needs.  Dickerson et al. (2003) highlighted some of 
these various factors in a study looking at healthcare utilization for persons with SMI.  
Problems included trouble getting through via telephone to the doctor, having to wait too 
long to see the doctor, no transportation, an office/clinic being closed, and not being able 
to afford care.  More than one of these barriers was experienced by 60% of the SMI 
population in this study, whereas in the comparison group- persons without SMI, only 
19% experienced more than one of these barriers.  Traditional physician office 
environments can also be a deterrent in seeking care.  In a qualitative study, those with 
SMI reported that their symptoms were exacerbated by long waits in the noisy and 
crowded waiting rooms at their primary care clinics, and therefore swift access upon 
entry was important to them (Lester, Tritter, & Sorohan, 2005).  This study inferred that 
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if these issues were improved, people with SMI would feel more comfortable in seeking 
regular care. 
Attitudes and behaviors of the physicians can also prevent ongoing, 
comprehensive, quality care for persons with SMI.  Negative attitudes toward people with 
mental illness could make a person with SMI feel stigmatized, and less motivated to seek 
care (Borba et al., 2012).  Lambert and colleagues (2003) cite several primary care 
physician-related factors that become barriers to treatment.  For example, primary care 
doctors often become preoccupied with the mental illness and do not pay close attention 
to the physical health aspects of persons with SMI.  Some doctors simply resist treating 
patients with SMI because of the complications of their mental illness, viewing their 
physical healthcare problems as psychosomatic complaints.  The authors also highlight 
that doctors report not having the time or resources to treat the complex physical 
healthcare problems of persons with SMI, as these appointments can take longer and be 
more intensive.  The recovery philosophy - the idea that people with SMI can recover 
from their mental illness - of the primary care physician (PCP) is also important to 
consumers with SMI.  In focus groups, people with SMI emphasized the need for the 
PCP to have a focus on their mental health recovery journey, stating that this would 
provide optimism in their physical healthcare treatment (Lester et al., 2005). 
People with SMI may also not be receiving high quality primary care.  Miller, 
Druss, Drombowski, and Rosenheck (2003) found that although 80% of those surveyed 
with SMI had access to primary healthcare, a majority expressed that the care offered did 
not meet their needs, and was not considered to be high quality care.  Of those surveyed 
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that had regular care, 14% said they still preferred to use the emergency room for their 
medical services because they did not feel their doctor provided good care.   
A Response to the Crisis: Integrated Care 
Historically, persons with comorbid mental health and medical issues would have 
to visit several sites to manage their illnesses.  This presented a barrier to comprehensive 
care, as challenges such as transportation, time management and financial resources 
would prevent someone from accessing needed providers (Druss & Bornemann, 2010).  
As awareness grew about the morbidity and mortality crisis of persons with SMI, so did 
advocacy of reducing these barriers by developing models of care that used a more 
collaborative partnership between mental health and medical providers, often referred to 
as “integrated care” (Butler, 2008). 
Integrated care has been conceived as medical and psychiatric providers working 
collaboratively and deliberately in their communications and actions to address the 
individual needs of the person with comorbid disorders within the context of a primary 
treatment setting (IOM, 2006).  Integrated care has evolved from the concept of “medical 
home”, where a person’s whole healthcare is addressed through a team of people working 
collaboratively (Mauer, 2008).  Integrated care for people with SMI is comprised of 
several  tenets, such as streamlined communication between physical and psychiatric 
providers (Goff, 2007), co-location of services (Druss, 2007), expanding the care 
paradigm of both psychiatric and general medical providers (Weiss, Haber, Horowitz, 
Stuart, & Wolfe, 2009), organizational and cultural changes that foster the holistic 
approach to providing services (Druss, 2007), and using a chronic care model to inform 
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disease management approaches (Horvitz-Lennon, Kilbourne, & Pincus, 2006).  
However, several different designs of integrated care exist.  Some integrated care models  
consist of primary care and psychiatric doctors who communicate and work 
collaboratively from their separate offices, while others use co-location and attend 
treatment team meetings together, and share medical and support staff.  There are also 
models where mental health staff are located in the primary care office, but the doctors 
remain separate (Butler, 2008).   
The use of technology has enhanced the ability for physicians to coordinate 
efforts.  Center for Medicaid and Medicare Services Innovation has recently funded 
projects that look at the meaningful use of electronic medical records, where “meaningful 
use” is defined as using technology to prescribe, communicate with patients, and keep 
records (Buntin, Burke, Hoaglin, & Blumenthal, 2011).  Specific to integrated care 
services, an electronic medical record can contain both primary and behavioral care data, 
allowing the providers to see the most updated changes made in their patient’s care (Tai, 
2012).  The use of a combined medical chart has the potential to further improve health 
outcomes, as accuracy and efficiency of the medical record available to providers at the 
time of appointment can facilitate the comprehensive and time-sensitive care of persons 
with comorbid conditions (Tai, 2012). 
The Substance Abuse and Mental Health Services Administration (SAMHSA) 
funded numerous integrated care programs across the country in the last several years 
(www.samhsa.gov/Grants/2010/awards/sm-09-011.aspx), which is in line with their 
10x10 initiative to increase the longevity of people with SMI by ten years within the next 
ten years (SAMHSA, 2008).  Because costs associated with co-location, electronic 
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medical record/information technology enhancements and hiring staff for an integrated 
clinic could be prohibitive in initiating these programs, the government commitment has 
helped to overcome the potential financial barriers in implementing these programs.  
Additionally, elements of the Patient Protection and Affordable Care Act could enhance 
the sustainability of these integrated care programs.  Medicaid expansion, increases in 
benefits to essential healthcare packages, and increased reimbursement for primary care 
(Croft, 2012) could further bridge the funding and service gap for people with SMI who 
would previously not be able to access or afford care. 
Integrating care might not be sufficient to address the complex physical 
healthcare needs of persons with SMI (Kathol, Butler, McAlpine, & Kane, 2010).  
Integrated care models have shown to improve access to care, thereby increasing initial 
visits and screenings, but several patient and physician elements have yet to be studied, 
such as patient health behaviors and treatment outcomes (Scharf, 2013).  This study 
proposes that understanding consumers’ physical healthcare decision-making autonomy 
preferences could inform primary care providers in creating a person-centered care 
atmosphere, which could enhance the treatment relationship and influence adherence 
recommended treatments, such as taking medication.  Improved adherence could 
ameliorate exacerbation of physical illness and could increase quality of life and 
longevity.    
Study Purpose 
 People with SMI are dying approximately ten to twenty-five years before persons 
without SMI, and the focus on what could help is lacking in the literature.  It is critical 
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that this problem be studied and addressed, in order to develop interventions that could 
lead to longevity and improved quality of life for persons with SMI.  There are several 
areas that need to be better understood about the physical healthcare of people with SMI. 
A review by Street, Elwyn, and Epstein (2012) suggests that a relationship exists between 
treatment adherence and physicians’ accommodation of patient preferences.  The authors 
conceptualize preferences as what patients want from their healthcare, and that these 
preferences, when germane to the problem at hand, should be honored in the spirit of 
providing high-quality and ethical care, and that the physical healthcare encounter should 
be studied from the perspective of the patient: the person who will ultimately be deciding 
on whether or not to follow through with treatment decisions.   
 Honoring patient preferences can positively impact treatment adherence.  A study 
that measured desired decision-making style and decisional conflict for persons with 
HIV/AIDS considering anti-retroviral therapy reported a decrease in decisional conflict 
about the therapy when their preferences were accommodated (Kremer, Ironson, 
Schneiderman, & Hautzinger, 2007).  Similarly, Katz et al. (2005) suggested that 
acclimating decisional preferences for women with breast cancer was directly related to 
having a mastectomy, being more satisfied with treatment (Lantz et al., 2005), and being 
less depressed (Vogel, Leonhart, & Helmes, 2009).  Also, evidence in primary care 
reported that when patients had more involvement in their decision-making, they reported 
fewer illness concerns, a stronger sense of control, and better symptom management 
(Brody, Miller, Lerman, Smith, & Caputo, 1989). 
The majority of studies about decisional preference and health outcomes focus on 
the general population, which highlights the lack of literature regarding the relationship 
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between decision-making autonomy preferences and adherence outcomes.  Additionally, 
there is limited literature that specifically addresses this relationship in the SMI 
population. The few studies done with the SMI population (which will be presented in 
chapter 2) have shown that their involvement in medical decisions has a positive effect on 
treatment acceptance and adherence (Loh et al., 2007; Simon, Loh, Wills, & Härter, 
2007); however, the literature also suggests that persons with SMI perceive their roles in 
decision-making as less participatory with their primary care providers than with their 
mental healthcare providers (Daumit, 2002). 
Mental healthcare literature provides substantial evidence that people with SMI 
desire a shared decision role in their psychiatric encounter (J. R. Adams, Drake, & 
Wolford, 2007; Deegan & Drake, 2006; Hamann et al., 2006a; Hamann et al., 2009).  
However, because of the lack of literature regarding decision-making autonomy 
preferences for persons with SMI in the primary care setting, it remains largely unknown 
what these preferences might be in an primary care setting and whether or not they are 
related to improved outcomes.  Therefore, the primary goal of this study is to better 
understand the physical healthcare decision-making autonomy preferences of persons 
with SMI, and how those preferences affect treatment adherence, specifically, their 
physical healthcare medication.   
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Chapter 2: LITERATURE REVIEW 
This review will begin by presenting a theoretical model adapted from the 
conceptual framework of Street, Elwyn, and Epstein (2012).  This will be followed by an 
in-depth look at the literature on decision-making for people with SMI in both mental 
health and primary care literature.  Finally, literature will be presented that supports the 
variables under study, leading to hypothesis formulation. 
Theoretical Framework 
 Figure 1 represents a theoretical model adapted from the conceptual framework of 
Street, Elwyn, and Epstein (2012), who use an ecological perspective to understand a 
patient’s healthcare experience.  It should be noted that the theory by Street, Elwyn, and 
Epstein is not specific to the SMI population, but is designed for the general population. 
 From an ecological perspective, the factors that create a patient’s experience 
could be related to culture and/or illness experience, as well as individual characteristics 
(Payne, 2005) - it is these factors that interact in complex ways, and which could inform 
how strongly a person feels about their decision-making in a primary care encounter.  
The strength of these preferences could then potentially influence whether or not a patient 
chooses to adhere to, or follow-up with, treatment.   
Another important factor of this ecological perspective is the patient’s perception 
of physician support of their decision-making autonomy preferences.  A great deal of 
literature addresses the relationship between perceived autonomy support and health 
outcomes.  Autonomy support is defined as a patient’s feeling that their wishes and 
preferences are being heard and honored by their physician, and research suggests that 
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physician autonomy support leads to improved health outcomes (G. C. Williams, 
Freedman, & Deci, 1998; G.C. Williams, Rodin, Ryan, Grolnick, & Deci, 1998). 
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Figure 1: Conceptual Model 
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Models of Decision-Making 
According to current literature, there are three presiding forms of treatment 
decision-making.  The first is paternalistic decision-making - where the practitioner 
makes the decision and the patient consents to that decision, the second is shared 
decision-making – where the patient is provided with detailed information regarding the 
illness and treatment options, and the practitioner and patient come to an agreement 
together, and, lastly, informed decision-making - where the patient has the information 
and the patient makes the decision completely separated from direct influence of the 
practitioner (Puschner et al., 2010).   
Entwistle and Watt (2006) further detail these models by comparing them side-
by-side (Table 1).  They suggest that there are three components which inherently 
separate each model:  information transfer, deliberation, and decision about implementing 
treatment.  The paternalistic model of decision-making has a one-way method of 
communicating: from doctor to patient, with minimum information provided to obtain 
informed consent.  The doctor deliberates alone, and the doctor makes the final decision 
about treatment options and implementation strategy.  In the shared decision-making 
model, the communication is two-way:  the doctor provides all the treatment option 
information, and the patient provides personal insights and preferences.  The doctor and 
patient make the decision together, and may bring others in, such as family and social 
supports, as well.  In the informed model, the communication is again one-way:  the 
doctor provides all the medical information necessary for the patient to make a decision 
on her/his own.  The patient then makes a decision (with possible discussion outside the 
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doctor’s office, with family or others) and the patient comes to her/his own conclusion 
and lets the doctor know how to proceed. 
Table 1. 
 Models of Decision-Making 
 Paternalistic Model Shared Decision-
Making 
Informed Model 
    
Information transfer One way (doctor to 
patient)- minimum 
information 
provided for 
informed consent 
Two way (doctor to 
patient and patient 
to doctor) 
One way (doctor to 
patient) all relevant 
information 
provided for patient 
to make decision 
    
Deliberation Doctor alone, or 
with other doctors 
Doctor and patient 
(possibly with 
support from 
others) 
Patient (possibly 
with support from 
others) 
Decision about 
implementing 
treatment 
Doctor Doctor and patient Patient 
 
Paternalistic Decision-Making 
Paternalism in healthcare has been a concern of medical professionals and 
researchers for several decades, and was addressed in the 1950s by Balint (1957), who 
compared person-centered and illness-centered care.  He challenged paternalism by 
moving patients to the center of the decision-making process instead of leaving them in 
the periphery.  Paternalism encompasses the compliance model, which places 
expectations of following doctor’s orders precisely and without question.  This does not 
allow for the flexibility of a person’s life experiences or preferences, and often results in 
a person’s drifting from the physician’s recommendations for treatment. 
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Shared Decision-Making 
Shared decision-making (SDM) suggests that there are two experts in the 
healthcare decision-making process, the patient and the practitioner.  SDM has three 
distinct elements: active participation of both patient and physician, information sharing, 
and agreement between patient and physician (Sandman & Munthe, 2010).  This 
approach has been touted as a necessary movement in medical care for several reasons.   
First, patients could become more responsible for their health and wellness, and 
physicians could hold patients more accountable to the agreement made between them 
(Hoving, Visser, Mullen, & van den Borne, 2010).  Second, patients and physicians could 
become more engaged and form a therapeutic relationship and trust, which is an essential 
component of effective communication (McCabe, Heath, Burns, Priebe, & Skelton, 
2002).  Finally, patients who are more involved in their treatment decisions are more 
likely to be satisfied with their care, and therefore more invested in treatment (Scheibler, 
2003). 
SDM holds to several social work values, such as a person’s right-to-choice and 
self-determination, person-centered care and empowerment of the client (Drake, 2010), 
while also strengthening the informed consent process.  As previously mentioned, 
informed consent is often obtained with inadequate information provided by the 
physician under the paternalistic model.  With the SDM model, information exchange is 
such that a patient is well-informed of their treatment alternatives, risks, and benefits and 
possible outcomes.  The patient therefore has a better opportunity to make an informed 
decision (King, Eckman, & Moulton, 2011).  Informed consent is a core tenet of the 
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social work code of ethics (NASW, 2008), and is also an imperative in all medical 
treatment and most research protocol, which could make the use of SDM a useful tool in 
a variety of settings. 
Informed Decision-making 
Informed choice/decision-making is a method where the patient makes the 
decision on her/his own after having been given all the relevant information about 
treatment alternatives (Puschner et al., 2010).  The patient might consult with family, 
friends, or significant others outside of the doctor’s visit, but in the end present the 
decision to the doctor as her/his own.  This model of decision-making has some 
underlying assumptions: that the patient does indeed have enough information to make an 
informed decision, that the patient has asked all the questions that she/he needs to ask, 
and that the patient is highly knowledgeable about the illness and how the different 
treatment options will impact his or her life.  This also assumes, to some extent, that the 
patient knows how to access information outside of the doctor’s expertise (e.g. other 
experts, research studies, the internet; (Puschner et al., 2010). 
Another assumption, similar to shared decision-making, is that the person is 
capable of making a rational choice, and that all the alternatives have been presented to 
the patient.  In many ways, the physician can continue to assert paternalism in both SDM 
and IDM, because they have control over what options are presented.  The patient may 
not be aware that certain options might be found undesirable by the physician, or that 
they might have negative outcomes, and so therefore will not be offered (Sandman & 
Munthe, 2010).  Therefore, a flaw with informed decision-making is that the doctor, 
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without a therapeutic bond to the patient, might continue to embody paternalism, while 
the patient is left in the dark.  Unless the patient chooses to do nothing, she/he is, in some 
respects, at the mercy of the treatment options available, unless more information is 
gathered outside the doctor’s office. 
Each of these models could have a place in the decision-making process.  
Consider the paternalistic style in the wake of a crisis: if someone has been in a car 
accident and is unable to make decisions for reasons of trauma or injury, and family are 
not accessible, paternalism could certainly be warranted and necessary.  In the case of 
someone who has a severe mental illness, the illness may be a barrier to comprehending 
that treatment is imminently necessary, given the risk of life or self-injury.  Another 
reason for using the paternalism approach is if the patient does not wish to be involved in 
making the decision.  A patient might defer the decision to the physician, even after 
attempts by the physician to engage and offer information and choices to the patient.   
Shared decision-making might fit where the above circumstances are not present.  
SDM also insinuates that there are options available, and that a decision needs to be 
made.  In some cases, no decision needs to be made because there are no treatments 
available, or there is only one treatment available, and the patient’s goal is wellness.  
SDM and the informed choice model might be ultimately appropriate when the treatment 
options come with high risk, or low benefit, or are controversial in nature (Puschner et 
al., 2010). 
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Decision-Making Autonomy Preferences in Mental and Physical Healthcare 
Healthcare decision-making autonomy preferences for persons with mental illness 
is a fairly new topic in the literature.  Prior to the 1990s, most healthcare decisions were 
made by the doctors in keeping with the paternalistic model (Sandman & Munthe, 2010).  
Since the 1990s, literature has begun to address healthcare decision-making for the 
general population, and even more recently, for the SMI population.  The literature about 
persons with SMI making physical healthcare decisions is still immature, and most of the 
studies to date look specifically at mental healthcare treatment decisions, not physical 
healthcare decisions. 
A great deal of literature in mental health supports the consumer’s desire for a 
shared decision-making approach, but less is known about persons with SMI and primary 
care decision-making.  There are three studies that specifically compare the mental and 
physical healthcare preferences of persons with SMI.  Adams et al. (2007) and O’Neal 
(2008) both found that persons with SMI preferred more autonomy in their mental health 
decision-making during their psychiatric encounters, but preferred a more passive role 
when it came to primary care.  Hamann and colleagues (2005) found that persons with 
SMI had a greater desire for autonomy in psychiatric care decisions than primary care 
patients for their general medical decisions.   
There are several studies that look at preferences strictly in mental healthcare, but 
no studies exist that strictly look at decision-making autonomy preferences for SMI in a 
primary care setting.  Some studies look at decision-making itself, finding that many 
doctors in primary care do not practice shared-decision making (Young, Bell, Epstein, 
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Feldman, & Kravitz, 2008); however, when SDM is practiced in primary care, patient 
satisfaction is higher (Loh et al., 2007). 
Perceived Autonomy Support and Treatment Adherence  
Treatment adherence is viewed as the key moderator between treatment 
recommendations and positive patient outcomes (Bosworth, Oddone, & Weinberger, 
2008).  Therefore, finding ways to increase adherence could, in theory, decrease 
morbidity and mortality for persons with SMI.  The relationship between autonomy 
support and physical healthcare treatment adherence in the general population has 
highlighted the need for physician awareness of patient preferences (Street et al., 2012) 
and studies have shown that honoring autonomy preferences has a positive impact on 
treatment adherence (G. C. Williams, Freedman, & Deci, 1998; G.C. Williams, Rodin, 
Ryan, Grolnick, & Deci, 1998).  Specifically, patients’ perceptions of physicians’ support 
for their autonomy has shown to improve long-term medication adherence (G.C. 
Williams et al., 1998), adherence to glucose control strategies related to persistent type II 
diabetes (G. C. Williams et al., 1998), adherence to weight loss and control activities 
(Silva et al., 2008), adherence to a smoking cessation regime (Geoffrey C. Williams et 
al., 2006), and adherence to injury rehabilitation pathways (Chan, Hagger, & Spray, 
2011).  However, this phenomenon has not been studied with persons with SMI in 
primary care.   
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Physical Healthcare Decision-Making Autonomy Preferences and Treatment 
Adherence 
As previously reported, people with SMI can have multiple comorbidities, and 
therefore managing their illnesses can be overwhelming.  Additionally, studies on these 
comorbidities have demonstrated that the medications used to treat mental illness can 
create serious physical health complications.  Therefore, persons with SMI need 
healthcare partners - providers who are person-centered and mindful of the specialized 
needs and circumstances for persons with SMI regarding their physical healthcare. 
Person-centered care is central to honoring a person’s self-determination and 
autonomy.  Person-centeredness, born of Carl Rogers’ client-centered theory (C. R. 
Rogers, 1977), has become a core tenet of social work theory and practice (Rowe, 1996).  
The values of person-centeredness in a medical setting would include the physician 
believing in the inherent worth and dignity of the person, and the physician holding a 
fundamental respect for the person’s freedom to decide, and also understanding that the 
person’s decisions are self-driven and goal-directed, even if the physician is unaware of 
the person’s goal (C. R. Rogers, 1977).  If a physician or care-giver is person-centered, 
this could increase the person’s feelings of being heard and valued.  Person-centeredness 
is therefore an essential component of the patient-physician dynamic, if it is to lead 
toward empowerment and self-determination on the part of the patient.  A physician who 
is person-centered will attempt to uncover and honor a patient’s preferences for his or her 
treatment decisions.   
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The consumer is the person who not only will play a role in the decision-making 
process, but will also be the one who does or does not execute the decision being made.  
Therefore, it is of the utmost importance to understand how much autonomy and control 
is desired in the decision-making process.  It has been shown that honoring decision-
making autonomy preferences has resulted in better engagement and treatment adherence 
(Loh et al., 2007; Raue, Schulberg, Heo, Klimstra, & Bruce, 2009; Stacey et al., 2008).  
This study looks specifically at medication as a form of treatment.  It has been suggested 
in the literature that when patients make the decision of what psychiatric medications to 
take, they are more likely to adhere to that medication (Wilder, Elbogen, Moser, 
Swanson, & Swartz, 2010). 
Honoring a person’s decisional preferences has shown positive outcomes in both 
mental health and primary care settings.  In a study by Hunot et al. (2007), patient 
preference for a different treatment decision than the one that was made (i.e. 
psychotherapy versus medication) was a predictor of non-use or discontinued use of 
antidepressants.  Similarly, Raue and colleagues (2009) found that preference strength for 
persons with depression in primary care was significantly associated with initiation of 
treatment and adherence rates at 12 weeks.  Unfortunately, the relationship between a 
person’s decisional preferences and adherence in physical healthcare making is nearly 
non-existent for persons with SMI, and so turning to the literature focused on the general 
population could shed some light, and assist in providing a comparison for this study’s 
focus on the SMI population.  However, the literature in physical healthcare linking 
patients’ decision-making autonomy preferences with treatment adherence is also limited.  
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The few studies that exist are newer in the literature, possibly revealing that this topic is 
currently gaining interest in the research community. 
A cross-sectional study of 4198 patients with diabetes who worked with 
physicians on self-management and follow-up care explored the possible relationship 
between patients’ decisional style preferences and diabetes treatment adherence (Heisler 
et al., 2009).  This study reported that patients who preferred shared decision-making 
over a physician-dominated style were more likely to adhere to the routine of three month 
A1C tests, which is an evaluation of glycemic control.  Participants who reported 
preferring completely autonomous decisions were more likely to adhere to their routine 
lipid test regime.  Overall, they found that patients who were more participatory in 
treatment decisions adhered to the scripted treatment regimens for diabetes care. 
A prospective cohort study of patients with depression explored the relationship 
of perceived decision involvement with treatment adherence and depression outcomes.  
Analyses showed that the more involvement they perceived to have in their treatment 
decisions, the more treatment adherent they were, and the more reduction in depression 
symptoms they experienced at six and twelve months (Clever et al., 2006).  The authors 
suggest that increasing patient involvement is key to improving treatment adherence and 
outcomes.   
These studies with the general population support the hypothesis that there is a 
positive relationship between a physician honoring patient’s decision-making autonomy 
preferences and improved treatment adherence.  Furthermore, there appears to be a more 
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specific association between the preference for shared decision-making, higher desired 
autonomy, and improved adherence and outcomes. 
Literature Support of Background Characteristics  
 As previously presented in the preference-health outcome theoretical framework, 
there are several factors that could impact both the individual decisional preferences and 
treatment adherence choices of persons with SMI.  The ecological perspective asserts that 
a complex interaction can occur between these factors (Payne, 2005), which could 
influence the strength of preferences as well as the adherence to those treatment decisions 
(Street et al., 2012).  This study specifically investigates the relationship between patient 
factors, decision-making autonomy preferences and medication adherence, however, 
there is inadequate literature exploring medication as a specific treatment.  Therefore, 
studies were reviewed that looked at treatment adherence, which includes medications in 
several studies. 
Influence of Age on Decision-Making Autonomy Preferences and Treatment 
Adherence.  
O’Neal and colleagues (2008) reported that both older and younger adults wanted 
shared decision-making related to psychiatric medications, but that older adults desired a 
more passive role regarding general medical decisions.  This finding was similar to that 
of Arora and McHorney (2000), who reported that younger patients (between 35 and 44 
years) preferred more control in medical decision making, claiming that older patients 
report having more trust in their physicians, therefore feeling comfortable leaving the 
decision to them. 
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Raue et al. (2009) found that among midlife and elderly patients with depression, 
three month treatment adherence rates were significantly related to patients’ treatment 
decision preferences being honored by their physicians.  Additionally, in a case study by 
Raue and colleagues (2010), it was highlighted that older patients with depression were 
more engaged in decision-making when presented with options.  Finally, in a meta-
analysis (Say, Murtagh, & Thomson, 2006), seventeen studies found that younger 
persons wanted more control of medical decisions than those who were older. 
Medical literature reports that older patients tend to be “good adherers” to 
medication versus younger patients (Hinkin et al., 2004).  However, Carney et al. 
reported that older persons with depression are significantly less adherent to physical 
healthcare medications than their non-depressed counterparts.  They found that depressed 
patients were only adherent 45% of the days measured versus 69% of the days for the 
non-depressed comparison group. 
Influence of Sex on Decision-Making Autonomy Preferences and Treatment 
Adherence.   
Studies that explore the differences between men and women regarding desired 
autonomy and control in medical decision-making report that women are more likely than 
men to want autonomy and an active role (Arora & McHorney, 2000; Dwight-Johnson, 
Sherbourne, Liao, & Wells, 2000; Levinson, Kao, Kuby, & Thisted, 2005).  Similar 
findings were reported by Dwight-Johnson et al. (2000), who found that women with 
affective disorders not only preferred more autonomy and control in treatment decisions 
than men, they also expressed that they had specific treatment preferences, where men 
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did not express a preference for one treatment over another.  Women were found to have 
more help-seeking behaviors, and to prefer a collaborative form of decision-making 
(Levinson et al., 2005).  Women also preferred to receive more information about their 
illness, and wanted to have pre-prepared questions answered (Arora & McHorney, 2000).   
Studies that investigate the relationship between sex and mental health treatment 
adherence for persons with SMI consistently report that women with SMI are more 
adherent to treatment follow-up than men with SMI.  Women engage in mental health 
services more readily than men (C. H. Brown, Bennett, Li, & Bellack, 2011) and in terms 
of medical interventions, women with SMI have sought out more preventative and 
diagnostic services (Xiong, Iosif, Bermudes, McCarron, & Hales, 2010).  Regarding 
ongoing, long-term medical intervention, women with depression who were HIV-positive 
were found to be more adherent to retroviral therapy than their male counterparts (Turner, 
Laine, Cosler, & Hauck, 2003).  Other studies suggest that the natural care-taking role of 
women could result in a desire for an active participatory role in their own healthcare 
decision-making (Arora & McHorney, 2000; Levinson et al., 2005).  There are no studies 
that specifically address the relationship between sex and medical decision-making 
autonomy preferences for persons with SMI; therefore, this study will explore this as new 
ground. 
Length of Time Attending Clinic, Decision-Making Autonomy Preferences 
and Adherence 
No studies were found specifically referring to the relationship of length of time 
attending an outpatient primary care clinic and decision-making autonomy preferences 
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and adherence for people with severe mental illness.  Three studies were found in general 
population literature and all three showed positive results.  Clayton et al. (2011) found 
that persons with longer time attending the clinic, most were able to achieve their 
preferred decision-making role.  Of those who reported not achieving their desired 
decision-making role, 16% were brand new patients, 16% were patients who had been 
attending less than a year, and 68% had been with the clinic multiple years.  A study 
exploring doctor advice on smoking cessation showed that length of time at clinic had a 
positive impact on patients quitting smoking (Hymowitz et al., 1997), and a prospective 
cohort study on diabetic patients showed that in a short time (14 months) at an integrated 
renal clinic (located in a general medical hospital), patients had improved hemoglobin 
A1c results (Patel, Shilliday, & McKay, 2009). 
The Influence of Severity of Mental Illness and Physical Disease on Decision-
Making Autonomy Preferences and Treatment Adherence.   
Decision-making capacity for persons with SMI is generally measured against the 
person’s functional level as it relates to the demands of a particular decision-making task 
(Wong, Clare, Holland, Watson, & Gunn, 2000).  The functions of competence include 
the ability to  1) understand the relevant information, 2) appreciate its implications for 
one’s situation, 3) reason with the information, and 4) express a treatment choice 
(Appelbaum, 2007).   
 Frequently, people with severe psychiatric disorders have competence questioned.  
For example, people with schizophrenia could have fluctuation in severity of psychiatric 
illness which could change level of functioning, and their capacity to make decisions 
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when acutely ill (Appelbaum, 2007).  Tan et al. (2009) also suggest that the seriousness 
of the healthcare decision determines the threshold for competence.  Therefore, the nature 
of the mental illness and the complexity of the physical healthcare decision to be made 
could confound capacity to make a treatment decision, and could be used as the clinical 
factors to determine if someone is able to make his own treatment decisions. 
 There are studies, however, that look at how persons with severe mental illness 
are able to make their healthcare decisions when their illness is well-managed.  Wong et 
al. (2000) found that people with SMI, when their symptoms were well managed, were 
not more impaired than the general population in decision-making when compared to two 
other groups: those who had learning disabilities, and those who had dementia.  A meta-
analysis (Okai et al., 2007) of 27 studies that looked at capacity of persons with SMI to 
make treatment decisions while on an acute inpatient psychiatric hospital found that 71% 
of those assessed were able to make treatment decisions.  Those that were deemed 
incapable (29%) suffered from severe psychosis. These studies indicate that those with 
acute psychotic illness that require hospitalization tend to have capacity problems, and 
would require more assistance with decision-making.    
 Perception of how serious the physical disease is can also impact the person’s 
desired level of decision-making involvement.  Levinson et al. (2005) found that healthier 
people were more likely to desire stronger involvement than those who were sicker.  
Similarly, Arora and McHorney (2000) found in their large study (n=2197) that patients 
with diabetes or heart disease were more likely desire a passive role than those with non-
serious hypertension.  It has also been found that disease trajectory (progression) can 
affect decision-making autonomy preferences.  As patients become more familiar with 
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their diagnosis and disease, learn better how to manage it and begin to feel better, they 
become more empowered to be more involved in their care decisions (Say et al., 2006). 
Much of the literature about treatment adherence for people with SMI focuses on 
compliance with psychiatric treatment.  Those studies that do explore physical healthcare 
adherence compare groups with and without SMI, and the consensus is that people with 
SMI are usually less adherent to treatment than those without (Kreyenbuhl et al., 2011).  
However, no difference in adherence was found across SMI diagnoses of schizophrenia, 
bipolar disorder, and major depression (Xiong et al., 2010).  The literature suggests that 
the cognitive impairment that can accompany severe mental illness can cause 
disorganization and loss of functioning, which could complicate adhering to a medication 
regime (Thames et al., 2011).  Perception of physical disease severity and its relation to 
treatment adherence has not been studied among the SMI population; however, a recent 
meta-analysis of studies on the general population reported a negative relationship 
between patient adherence and illness severity perception (DiMatteo, Haskard, & 
Williams, 2007) - people who self-reported more serious diseases were less adherent to 
treatment than those who reported perceiving their disease as less serious.   
The Influence of Social Support on Decision-Making Autonomy Preferences 
and Treatment Adherence.   
In the seminal article by Cohen and Wills (1985), social support is defined in two 
ways: interpersonal resources (e.g. friends, family) and the larger social network 
(community embeddedness).  In an extensive systematic review, they report that having 
interpersonal support has a buffering effect on stress that occurs during critical events.  In 
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the mental health literature, social support is also defined in two specific ways: informal, 
as in support from families, friends, and others in the interpersonal network, and formal, 
as in professional mental health or other staff who are paid to participate in the care of the 
individual (Clark, 2001; Cummings, 2009).  Cummings and Kropf (2009) studied the 
differences where formal and informal supports are observed in the lives of people with 
SMI.  They found that formal support (from professionals, such as mental health 
workers) was most often in the form of assistance with psychiatric symptom coping, 
physical health, information, and dangerous behavior.  Informal support (family, friends) 
was most often in the form of assistance with self-care activities, symptom coping, and 
money management.   
Literature shows that people with SMI report lower amounts of informal social 
support than those without mental illness (Kilbourne, McCarthy, Post, Welsh, & Blow, 
2007).  This could be the result of caregiver burden or burnout due to behaviors resulting 
from poorly managed illness (Loukissa, 1995), or because of loved one’s self-stigma 
(Hasson-Ohayon, Levy, Kravetz, Vollanski-Narkis, & Roe, 2011).  This is an unfortunate 
situation, because the benefits of informal support for people with SMI are clear in the 
literature.  It has been reported that informal social support has had a positive impact on 
symptoms (S. E. Rogers, Anthony, & Lyass, 2004; Travis, Lyness, Shields, King, & Cox, 
2004) and can help reduce or eliminate the abuse of substances (Clark, 2001).  
Additionally, informal social support has shown positive outcomes in general healthcare.  
In a meta-analysis of 122 studies over nearly fifty years in the general population, 
DiMatteo (2004) reported a significant relationship between several aspects of informal 
social support, including practical and emotional support, and medical treatment 
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adherence. It was found that practical support (e.g., assistance with transportation and 
money) had the greatest impact on treatment adherence.  However, this review excluded 
healthcare visits that were psychiatric in nature, and does not flesh out the types of 
adherence, so, although the DiMatteo review provides a basis for conjecture about how 
social support affects treatment adherence, it is not specific to medication adherence for 
those with SMI. 
A great deal of literature addresses the impact of professional support on client 
outcomes in mental health treatment.  Several models of case management have been 
evaluated and have shown positive impact on hospitalization rates (Bond, McGrew, & 
Fekete, 1995; Burns, Fioritti, Holloway, Malm, & Rossler, 2001) as well as homelessness 
and employment (Bond, Salyers, Rollins, Rapp, & Zipple, 2004; Mueser, Bond, Drake, & 
Resnick, 1998).  However, no studies have been done that highlight the influence of 
formal support on physical healthcare outcomes for the SMI population.  An apparent gap 
in the literature exists regarding the impact of formal and informal support on physical 
healthcare treatment adherence.  However, the mental health literature shows that such an 
impact exists, which would support a hypothesis that the more support (formal and/or 
informal) a patient has, the more adherent they are to treatment. 
Barriers and Facilitators of Medication Adherence 
Much of the literature dedicated to exploring the reasons why people with SMI do 
not take their medications as prescribed is specifically limited to 1) their psychotropic 
medications (medications taken for their mental illness) and 2) non-adherence risk factors 
associated with mental illness.  No studies were found that specifically gleaned 
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facilitators and barriers to medication adherence in primary care for persons with SMI 
from their perspective.  With integrated care and medical home initiatives, more and 
more primary care providers will be addressing physical, and even some mental, 
healthcare issues for persons with SMI, which makes this information critical and useful 
in navigating the future of attending to the comorbid needs of this population.  
Several studies cite severity of mental illness and poor insight as the primary 
reason among people with SMI to stop taking their psychiatric medications and more 
than 50% of people with SMI are found to go off of their medications within a year of a 
hospitalization (Zygmunt, Olfson, Boyer, & Mechanic, 2002).  However, what do people 
with mental illness say about the reasons they do not stay on their medications?  A focus 
group of persons with depression and anxiety explored the things they perceived would 
be helpful for their illness.  The group members cited psychotherapy treatments and 
medications, however, they all preferred the former to the latter as a primary treatment 
method (Prins, Verhaak, Bensing, & van der Meer, 2008).  The authors suggested that 
perceived need for type of treatment could influence whether someone is adherent to 
prescribed treatment.  Therefore, perception of not needing a form of treatment (and 
therefore not following doctor’s orders) might be labeled in the literature as “no insight” 
or “non-compliance” when, in fact, the reasons could be further explored qualitatively, 
adding to the potential intervention implications for the field.  A study by Wilder et al. 
(2010) elaborates on this idea: when consumers pre-state their desired medications, they 
are more likely to adhere to those medications.  They found that consumers who stated 
their medication preferences ahead of time were 1) more likely to have those prescribed 
and 2) were more adherent at 12 months.  This could imply that preferred decision-
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making autonomy of the person was honored, which facilitated adherence.  Because the 
literature in this area is limited, this study will explore new ground in uncovering the 
reasons why people with SMI adhere or do not adhere to their prescribed physical 
healthcare medications. 
Summary, Study Aims, and Hypotheses 
 This review highlights the current glaring gap in the literature: physical healthcare 
decision-making autonomy preferences have not been adequately studied for persons 
with SMI in the primary care setting, nor has the relationship been explored between their 
physical healthcare decision-making autonomy preferences and treatment adherence.  
Some of the current studies in the mental health/psychiatric field are plagued with 
problems common to research in the social sciences: low samples size and power, non-
random sampling, reliability and validity challenges of measures, and qualitative methods 
without triangulation, peer and member checking.  The literature guiding this study is 
presented to support the conceptual model and theory underpinning this study.  However, 
much more evidence resulting from rigorous studies is needed to further inform the social 
work, psychology, and medical fields on how best to create a decision-making 
environment that will support the physical wellness goals of each individual with SMI.   
 Based on the theory and research related to this topic, two major considerations 
have emerged.  First, preferences for decision styles could vary, based on age, gender, 
race/ethnicity, severity of illness, perceived severity of physical disease, and perceived 
external support.  Second, supporting decision-making autonomy preferences related to 
treatment adherence are present for the general population (Street et al., 2012), but this 
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same phenomenon has not been studied among the SMI population.  From these 
considerations, the following aims and hypotheses are proposed: 
Specific Aim 1.  To identify what factors contribute to the physical healthcare 
decision-making autonomy preferences of persons with SMI. 
Hypothesis 1. Physical health decision-making autonomy preferences can be 
predicted by patient characteristics of age, sex, length of time at clinic, mental illness 
severity, physical health severity, and perceived social support.  It is hypothesized that 
patients who are younger, female, have less severe mental illness, have less severe 
physical health issues, and higher levels of perceived social support, desire more 
autonomy.   
Specific Aim 2. To identify the impact of physical healthcare decision-making 
autonomy preferences on medication adherence. 
Hypothesis 2.  When controlling for patient characteristic variables (listed 
above), higher levels of desired autonomy in decision-making and perceived autonomy 
support from physician will predict higher levels of (primary-care prescribed) medication 
adherence. 
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Chapter 3: METHODS 
Study Design 
 The purposes of this three-month longitudinal study were to explore the complex 
relationship between the characteristics of people with SMI and their decision-making 
autonomy preferences in a primary care context, and to identify how these preferences 
are related to medication adherence.  A convenience sample of adults (age 18 years and 
older) with SMI was used, and the participants were either new or returning patients to 
the integrated care clinic.  Three researchers were involved in data collection, the primary 
investigator (PI) of the study, from the University School of Social Work and two 
research assistants affiliated with the University Psychology Department.  The research 
assistants had been involved with a previous study that was similarly designed, and 
therefore had experience with the measures and procedures involved in this study.   The 
members of the research team completed all the University required IRB and study-
related training.  The research assistants were monitored by the PI, who provided training 
to ensure accurate data collection.  All three research staff stayed in close communication 
and used a spreadsheet to organize recruitment.  The PI performed all the data entry for 
all the measures.  The follow-up (Time 2) phone contacts were made by the PI and a 
research assistant.  The calls were scripted and the script was followed closely. 
Study Participants and Setting 
This study was conducted at an integrated primary care clinic located onsite at a 
CMHC in Indianapolis, Indiana.  All consumers of the CMHC are offered participation in 
the clinic, with over 400 of a potential 700 currently participating after two years in 
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operation.  At the time of data collection, the clinic was actively recruiting new referrals, 
so that numbers were consistently increasing during this study recruitment.  Thirty to 
forty patient appointments were scheduled per week.  The goal was to recruit at least 15 
participants a week for ten weeks, spread out over a four month period. However, the 
recruitment faced several issues, which will be outlined in the results section. 
This clinic was staffed by one primary care physician, one registered nurse, and 
one licensed practical nurse.  The clinic was started through a service grant provided by 
SAMHSA, and is among several others similarly funded programs around the country.  
The primary care team met with the CMHC teams weekly to review cases and address 
any concerns about mental and/or physical health treatment.  A database was kept by an 
administrative assistant to identify which consumers from what mental health teams are 
seen in the primary care clinic.  The purpose of the cross-communication between the 
primary care staff and the mental health staff was to provide an integrated approach to 
care in addition to co-location. 
Study Procedures 
Approval for this study was granted by the Indiana University Purdue University 
Indianapolis (IUPUI) Institutional Review Board.  Participants were approached at the 
integrated care clinic waiting area after they finished an appointment with their physician.  
They received a brief explanation of the study, and were asked if they were interested in 
participating.  If they agreed, the informed consent process took place.  After informed 
consent was read to the participant, a short quiz about the nature of the study was given to 
assess their ability to understand to what they were consenting.  If the participant 
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answered all five questions correctly, the participant continued in the study.  If they were 
unable, they could retake the quiz up two more times.  If the participant did not pass the 
quiz in three tries, they were considered ineligible.  This method of consent 
comprehension has shown to have some effectiveness in increasing understanding and 
ability to consent for research (Hochhauser, 2008).  Of the participants initially recruited 
for the study, only two were unable to pass the consent quiz in three attempts, and they 
were therefore excluded from completing the measures. 
 After completing the informed consent process, participants were asked for 
contact information including telephone numbers (home and cell), and for an email 
address, if applicable, in order to contact them for collecting three month measures.  
Upon consent, Time 1 measures were administered by one of the research staff.  After 
completion of surveys, participants were given a gift bag with several small hygiene 
items, such as toothbrush and toothpaste, soap, shampoo, and deodorant.  They were also 
made aware that after they complete the three month measures, their names will be 
entered into a drawing for one of five $50 gift cards to a retail outlet.  At the completion 
of the study, five participants who completed the study were randomly selected and were 
given a gift card. 
 At Time 2 (three months from Time 1), participants were called by one of the 
research staff and asked if they would be willing to complete the short, follow-up 
questions, which consisted of the four medication adherence yes/no questions and the two 
medication adherence facilitators and barriers open-ended questions.  Multiple attempts 
were made to reach the participant within a one-month window following the three-
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month mark.  If they could not be reached during that time, or if their phone was 
disconnected, a note was made in a log and no more attempts were made.   
Measures and Instruments 
 Background characteristics such as sex, age, perceived social support, severity of 
mental and physical health, and length of time attending the clinic were used to predict 
autonomy preferences in physical healthcare decision-making for the first hypothesis.  
These background variables were controlled for in the second hypothesis.  Then, the 
variables of perceived autonomy support and autonomy preferences were added to the 
model to observe the impact on medication adherence at Time 2.  Table 2 displays a list 
of variables and measurement scales. 
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Table 2. 
Variables and Measurement Scales 
Variable Measure Description 
   
Age Self-Report Age in years 
   
Sex Self-Report 1= male 0= female 
   
Ethnicity 
 
Self-Report 1= American 
Indian/Alaskan Native 
2= African American 
3= Asian 
4= Caucasian 
5= Other 
   
Race Self-Report 1= Hispanic/Latino 
2= Not Hispanic/Latino 
 
   
Length of Time at 
Clinic (months) 
Medical Record Number of months 
attending clinic 
   
Mental Illness 
Symptom Severity 
Colorado Symptom 
Inventory (Shern, Lee, 
& Cohen, 1996) 
 
-16 items 
-Self-administered 
-Good internal consistency 
and test-retest reliability 
-α=.86 
   
Perceived physical 
illness severity 
Short Form-12 (Ware, 
Kosinski, & Keller, 
1996)  
-6 items (physical health 
domain) 
-Self-administered 
-Good correlation with 
previous larger version  
-Good test-retest reliability 
-α=.82 
   
Perceived social 
support 
Interpersonal Support 
Evaluation List (ISEL) 
- Appraisal 
- Assist 
- Belonging 
-30 items 
- 3 subscales 
-Self-administered 
-Good test-retest reliability 
and internal consistency 
-α=.82 (appraisal) 
-α=.80 (assistance) 
-α=.87 (belonging) 
   
Who is providing 
social support? 
Single Question 
Researcher Developed 
-Self-administered 
   
Autonomy 
Preferences 
The Autonomy 
Preference Index, 
Decision-Making Scale 
(Ende, Kazis, Ash, & 
Moskowitz, 1989) 
 
-15 total questions 
-6 general questions (4 for 
analysis) 
-9 vignette questions, three 
for each of three vignettes 
-Self-administered 
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-Good reliability 
-α=.81 (total scale) 
   
Perceived 
Autonomy Support 
The Health Climate 
Questionnaire (G.C. 
Williams, Grow, 
Freedman, Ryan, & 
Deci, 1996) 
-6 questions 
-Self-administered 
-Good internal consistency 
-α=.97 
   
Medication 
Adherence 
Morisky Medication 
Adherence Scale 
(Morisky, Green, & 
Levine, 1986) 
-4 questions 
-Self-administered 
-Good internal consistency 
and sensitivity 
-α=.51 (Time 1) 
-α=.48 (Time 2) 
   
Barriers and 
Facilitators to 
Treatment 
Adherence 
Open ended question at 
3 months (Time 2) 
 
-Interviewer-administered 
-Participants were asked 
what, if any, barriers and 
facilitators they 
experienced regarding 
treatment adherence 
 
Background Characteristics  
 Background variables such as sex, age, ethnicity, and race were all collected at 
Time 1 using data sheet developed by the researcher.  Number of months attending the 
clinic as well as mental and physical health diagnoses was all obtained from the 
participants’ medical chart. 
Severity of Mental Illness Symptoms 
 Severity of mental illness was assessed by the Colorado Symptom Inventory 
(Shern et al., 1996).  The Colorado Symptom Inventory (CSI) is a self-report measure of 
psychiatric symptoms, in which respondents report on the frequency of the various 
symptoms they have experienced in the last 30 days.  A five-point Likert scale was used 
for the 16 questions (no subscales), with 1= not at all, 2= once during the month, 3= 
several times during the month, 4= several times a week and 5= at least every day.  
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Examples of questions are “In the past month, how often have you told others you acted 
‘paranoid’ or ‘suspicious’?” and “In the past month, how often did you hear voices, or 
hear or see things that other people didn’t think were there?”  In a study on the 
psychometric properties of the CSI with the homeless population with SMI, Conrad et al. 
(2001) found that the CSI had excellent internal consistency  (α = .90) and a good test-
retest reliability (r = .79).  Boothroyd and Chen (2008), in a follow-up study on the 
psychometrics of the CSI using a sample of 3,784 adult Medicaid respondents, also found 
that it had excellent internal consistency (.92) and good test-retest reliability (.71).  
Regarding validity, Conrad and colleagues also tested the CSI against the Brief Symptom 
Inventory and all the hypothesized relationships were in the predicted direction and were 
statistically significant.  The CSI’s internal consistency reliability was analyzed for this 
current study and for comparison to previous literature.  For this sample, internal 
consistency was good (α=.86), but was slightly lower than previous findings with similar 
samples.  A single summary score was used for analysis, with a higher score indicating a 
higher perceived severity of mental illness. 
Severity of Physical Illness 
 The Short-Form Health Survey 12 (SF-12) was used to measure severity of 
physical illness.  The SF-12 is a self-report tool developed from the SF-36 (Ware & 
Sherbourne, 1992) with two specific domains: mental health (referred as MCS- Mental 
Component Summary) and physical health (PCS- Physical Component Summary), with 
six questions for each domain.  Only the physical health domain (six questions) was used 
for this study.  Respondents were asked to rate a question about their general health, 
using a five-point Likert scale, with a score of 1indicating “excellent” and a 5 indicating 
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“poor”.  The next three questions ask the impact of physical health on activities, using a 
three-point scale, with a 1 indicating “limited a lot” and a 3 indicating “not limited at all.”  
The final two questions ask about impact of physical health on daily activities, impact of 
pain on daily life, and impact of physical health on social activities, again using a 5-point 
Likert scale with 1= “all of the time” and 5= “none of the time”.  Ware et al. (1992) 
found the components of the SF-12 to be correlated with the related components of the 
SF-36, with stability over a two- week period of .89 (PCS).  In a study using the SF-12 
with a large sample of persons with SMI (n=946), Salyers et al. (2000) found that the 
instrument distinguished the respondents with SMI from the general population, had a 
good test-retest reliability (PCS= .73) over one week, a two-factor distinction was 
confirmed and the scale was related to other similar indexes as expected.  Internal 
consistency for this study sample was good (α=.82).  A summary score was created using 
oblique confirmatory factor analysis (Fleishman, Selim, & Kazis, 2010) for the physical 
health components of the scale.  Higher scores indicated more severe physical health 
problems. 
Social Support 
Social support was measured using the Interpersonal Support Evaluation List (S. 
Cohen & Wills, 1985).  The ISEL measures perceived support using four different 
domains: perceived ability of someone to do things with (belonging), the perceived 
availability of someone to talk about problems with (appraisal help), perceived 
availability of practical aid (assistance), and perceived availability of a positive 
comparison when comparing one’s life to someone else’s (self-esteem support).  Rogers 
et al. (2004) tested the reliability and validity of the ISEL with people with SMI.  They 
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found evidence to support a three-factor structure by combining self-esteem and 
belonging.  Coefficient alphas for the three subscales ranged from .82 to .88 with a total 
scale coefficient of .92.  The authors found that the reliability and validity testing with the 
SMI population approximated the general population (S. Cohen & Wills, 1985).  The 
scale has 30 items, with three subscales, and 10 items in each subscale.  Respondents 
were asked to indicate how much support they perceived receiving.  Examples of items 
from the three subscales include: “There are several people I trust to help solve my 
problems” (appraisal), “If I needed help fixing an appliance or repairing my car, there is 
someone who would help me” (assistance), and “I often meet or talk with family or 
friends” (belonging).   Internal consistency reliability for this study was strong: total scale 
(α=.92), appraisal (α=.82), assistance (α=.80), and belonging (α=.87). 
After recoding several reverse-worded questions, summary scores were created 
for each of the three subscales for analysis, with higher scores indicating higher perceived 
support.  To further identify specific support networks, a single question asking the 
participant to name their primary support person(s) was added by the primary investigator 
to the end of the ISEL.  Several participants provided two or more people who provided 
support, however, when this occurred, respondents were asked to clarify who provided 
more support.  The person named by the participant as providing more support was 
placed in a “primary support” category.  Other supports were put in “secondary support” 
and in the case of one participant who listed three different supports a third; “tertiary 
support” category was used.  The responses were then coded into specific relationship 
categories (e.g. sibling, parents, spouse/partner/significant other, mental health 
professional, other professional) and then condensed into smaller categories of formal 
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(professional, i.e. mental health case manager) and informal support (family, friends, 
neighbors, roommates). 
Autonomy Preferences in Medical Decision-Making 
 The Autonomy Preference Index (API), decision-making scale (Ende et al., 1989) 
was used to measure patients’ preferences for taking an active role in their own care and 
how these preferences are affected by varying disease severity.  The API has two 
subscales: information preferences and decision-making autonomy preferences.  The 
decision-making preference subscale was used for this study, to keep the focus on the 
decision-making dimension.  The API decision-making preference subscale consists of 
15 items, divided into two sections.  The first section contains six general questions about 
decision-making, and nine items related to three clinical vignettes.  The six general 
questions ask when the participant feels they should make the decision, or when they 
should allow the doctor to make the decision for them.  For example, the first question 
asks the participant to rate the statement, “The important medical decisions should be 
made by your doctor, not by you” and the second statement is “You should go along with 
your doctor’s advice even if you disagree with it.”  The six general questions ask the 
respondents to rate the extent to which they agree with each statement on a five-point 
Likert scale with 1= “strongly disagree” to 5= “strongly agree”.  After appropriate 
recoding, item analysis revealed two items with poor item to total scale correlation 
(α=.42).  Once these two items were eliminated, reliability improved toward acceptable 
(α=.70).  These four items were then used to create a summary score.  The higher the 
score, the more autonomy the participant preferred. 
 
 
46 
 
In the vignette section, each vignette describes an illness and the severity of 
illness increases with each vignette.  The first vignette represents an upper respiratory 
tract illness, the second vignette describes high blood pressure, and the third describes 
myocardial infarction (heart attack).  The three questions that follow each of the three 
vignettes are unique to that vignette.  The questions following the first vignette about 
upper respiratory illness are “Who should decide”… 1) Whether you should be seen by a 
doctor, 2) Whether you should have a chest x-ray, and 3) Whether you should try taking 
some cough syrup.  The questions following the second vignette about high blood 
pressure are “Who should decide”… 1) When your next visit to check your blood 
pressure should be” 2) Whether you should take some time off work to relax, and 3) 
Whether you should be treated with medication or diet.  The questions following the third 
vignette about a heart attack are: “Who should decide… 1) how often nurses should wake 
you up to check your temperature and blood pressure, 2) Whether you can have visitors 
outside of your immediate family, and 3) whether a cardiologist should be consulted.  
The response choices are the same for each question following each vignette scenario: 1= 
“you alone”, 2= “mostly you”, 3= “the doctor and you equally”, 4= “mostly the doctor,” 
and 5= “the doctor alone”.  
In a previous study, test-retest reliability for the entire scale with a sample in a 
two-week interval was .84, and Chronbach’s alpha coefficient was .82.  This scale has 
been used in several mental health studies with the SMI population (J. R. Adams et al., 
2007; Hamann et al., 2005; Hamann et al., 2006b; O'Neal et al., 2008); however, none of 
the studies reported psychometrics for the scale when used with persons with SMI.  With 
this study sample, the vignette section had somewhat better internal consistency (α=.78) 
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than the general scale (α=.70) and the general (with the reduced 4-item scale) and 
vignette scales taken together had good reliability (α=.81).  For analysis, after recoding 
negatively-worded items so that higher scored items indicated more autonomy, a 
summary score was created for the total scale (both general scale and vignette scales 
together).  For the total scale, higher scores indicated more desired autonomy. 
Perceived Autonomy Support 
 The level of autonomy support from the physician as perceived by the patient was 
measured by the Modified Health Care Climate Questionnaire (HCCQ).  This measured 
how much the patient perceived the support from the physician for their desired decision-
making autonomy.  The HCCQ is a six-item scale modified from an original 15-item 
scale designed to assess the perceived autonomy of persons seeking care for obesity and 
weight loss (G.C. Williams et al., 1996).  The modified version consists of questions that 
are most representative of the concept of autonomy support (G.C. Williams et al., 1998).   
It has been successfully used with diabetic patients regarding glucose control methods 
(G. C. Williams, Lynch, M., Glasgow, R.E., 2007)  as well as in an adherence study for 
patients with various chronic conditions that require long-term medication treatment  
(G.C. Williams et al., 1998).  The questions explore how the patients feel about their 
encounters with their doctors, specifically regarding whether their autonomy desires were 
honored.  The scale asks the responder to rate questions like “I feel that my physician has 
provided me with choices and options” and “My physician encourages me to ask 
questions”.  Perceived autonomy support questions are rated on a five-point Likert scale, 
with 1= “not true at all” to 5= “very true”.  The modified scale has a Chronbach’s alpha 
of .80 and is highly correlated with the original scale (r=.91).  A factor analysis with a 
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sample of 1,183 participants yielded an one-factor solution, with all factors loading at or 
above 0.74 (G.C. Williams et al., 1996).  This scale has been used in one study of 
Chinese persons with SMI (Chiu, Ho, Lo, & Yiu, 2010), but psychometrics were not 
reported.  For this study, internal consistency was strong (α=.97).  A summary score was 
used for analysis, with a higher score indicating a stronger feeling that autonomy was 
supported. 
Medication Adherence 
Several methods exist to collect data on medication treatment adherence, 
including pill counts, chemical tests, pharmacy data, and self-report.  For feasibility, this 
study used the self-report method.  The Morisky Medication Adherence Scale (Morisky 
et al., 1986) is widely used as a measure of medication-taking behavior.  The theory 
undergirding the MMAS is that medication non-adherence can happen in several ways, 
such as forgetting, carelessness, stopping the drug when patient feels better, or starting 
the drug because patient feels worse.  Patients tend to want to give their providers a 
positive response about taking medication, but by using questions that reverse the 
wording of the non-adherence areas, a measure of non-adherence can be achieved by the 
sum of the answers “yes” to the four questions.  This self-report scale asks questions such 
as “Do you ever forget to take your medicine?” and “Are you careless at times about 
taking your medicine?” with simple “yes” or “no” responses.  The scale was administered 
at Time 1 and repeated at Time 2.  Responses of “no” was coded as “0” and responses of 
“yes” was coded as “1”, and a summary score for the four items was used for analysis, 
with a higher score indicating higher non-adherence to physical health medication. 
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 Although reliability from a longitudinal study using the scale was not quite 
adequate (Chronbach’s alpha= .61), each item on the scale significantly contributed to the 
overall reliability coefficient, and the alpha decreased if any one of the items was deleted.  
Additionally, the scale was identified as one-dimensional through a principal components 
analysis (Morisky et al., 1986).  The scale was also found to have good sensitivity (.81) 
and specificity (.44) and was able to predict adherence in both high and low index score 
categories of controlled blood pressure patients (Morisky et al., 1986).  The scale has 
been used in a recent study (Bates, Whitehead, Bolge, & Kim, 2010) with a large group 
of people with bipolar disorder (n=1,810) and was found to correlate strongly with a 
medication satisfaction scale, however, specific psychometrics for the MMAS were not 
reported.  Internal consistency for this study was also inadequate (α=.51) at Time 1, and 
(α=.48) at Time 2. 
Barriers and Facilitators to Medication Adherence 
 At three month follow-up, two open-ended questions were asked to solicit 
participants’ perspectives on barriers and facilitators to physical health medication 
adherence.  The responses were recorded verbatim in a data collection sheet.  The 
specific open-ended questions were: “What barriers, if any, do you experience following 
the medication orders given to you by [insert primary care doctor’s name]?” and “What 
helps, if anything, successfully following the medication orders given to you by [insert 
primary care doctor’s name]?”   
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Data Analysis    
Preliminary analyses 
 IBM Statistical Package for the Social Sciences (SPSS) version 20.0 was used for 
all analyses.  Means and standard deviations were calculated for all continuous variables.  
Data were inspected for normality, assessing for skewness and kurtosis.  Data were 
initially screened visually for normality using histograms (Field, 2009).  All data were 
normally distributed except for months attending the clinic, which were positively 
skewed.  There were more people who were new to the clinic, which accounted for the 
non-normal distribution.  Residual plots were then inspected for regression variables and 
found to be homoscedastic, as the data on the plots appeared linear when a line was 
applied (Field, 2009).  All scores from surveys were transformed into summary scores 
unless otherwise indicated.  Data analysis was organized around each hypothesis.  The 
level of significance for statistical tests was set at .05. 
Hypothesis 1: Physical health decision-making autonomy preferences can be 
predicted by patient characteristic variables of age, sex, length of time at clinic, 
mental illness severity, physical health severity, and perceived social support.  It 
is hypothesized that patients who are younger, female, have less severe mental 
and physical health problems, and higher levels of perceived social support, will 
prefer higher level of desired autonomy. 
As there were several independent variables in this model, chances of 
multicollinearity, or shared variance, between the independent variables, were higher 
than models with fewer independent variables (IVs) (Pedhazur, 1997).  Therefore, 
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methods were used to check multicollinearity such as observing the correlations, as well 
as the values for the tolerance and the variance inflation factor (VIF).  Pearson’s r 
correlations were used to determine the magnitude and direction of the bivariate linear 
relationship between each independent variable and the dependent variable (DV) and to 
observe which independent variables, if any, were highly correlated (Nathans, Oswald, & 
Nimon, 2012).  According to Field (2009), multicollinearity exists when variables are 
correlated at .70 or higher.  The highest significant correlations between predictors were 
the three subscales for social support, and this relationship would be expected as they are 
three dimensions of a single scale.  The highest correlation between the subscales was the 
belonging factor and the assist factor of the ISEL (r= .72).  The two subscales with the 
smallest effect sizes with the dependent variable were dropped from the model 
(belonging and assistance), while appraisal of social support was kept for the regression 
analysis.  All other significant correlations between independent variables were low to 
moderate (r= .21-.62). 
Multiple linear regression was used to predict desired autonomy preferences for 
physical healthcare.  The dependent variable of desired autonomy preferences for 
physical healthcare was analyzed using the summary score from the Autonomy 
Preference Index total scale (combining the general scale and the vignette scale).  The 
predictor variables for analysis were age, sex, months attending the clinic, severity of 
psychiatric symptoms (a summary score from the Colorado Symptom Inventory [CSI]), 
perceived severity of physical illness (a summary score from SF-12 physical health 
subscale), perceived social support (three summary scores from the subscales of 
Interpersonal Support Evaluation List). 
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Hypothesis 2: When controlling for characteristic variables (listed above), it is 
predicted that the higher the preferred autonomy for physical healthcare decision-
making and perceived autonomy support from the physician, the more adherent 
the person will be to medication.   
Hierarchical multiple regression (HMR) was used to analyze the second 
hypothesis (J. Cohen, Cohen, West, & Aiken, 2003).  HMR evaluates the relationship 
between a set of independent variables, controlling for the impact of a different set of 
independent variables on the dependent variable.  Variables are loaded in a sequence of 
blocks that may contain one or more variables.  The order of variable block entry is pre-
determined by the author, and is related to the theory driving the model (Schafer, 1991).  
The conceptual model (Figure 1) in this study asserts that there is a hypothetical 
relationship between autonomy preferences and medication adherence.  The first block of 
predictors was entered as control variables, and then the second block, which contained 
the autonomy preferences and autonomy support variables, was entered, in order to 
identify how much variance in medication adherence is uniquely contributed by the 
second block.  This is done by observing the change in the variance (r2) between the two 
models.  In block 1, the continuous variables of sex, age, length of time attending the 
clinic, the summary scores of the three dimensions of social support from the ISEL 
(appraisal, assistance and belonging), physical (SF-12, physical health scale) and mental 
health severity (CSI) were entered as controls for the first model.  In block 2, the 
summary scores for autonomy preferences (total API scale) and perception of autonomy 
support (HCCQ) were entered to create the second model. 
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 Lastly, semi-structured questions in sequence were used to ask two questions 
during Time 2 data collection.  The two questions were:  “What barriers, if any, do you 
experience following the medication orders given to you by [insert primary care doctor’s 
name]?” and “What helps, if anything, successfully following the medication orders 
given to you by [insert primary care doctor’s name]?”  These two questions were asked 
of follow-up participants until responses were becoming redundant.  As data were being 
collected, initial reviews and observations led to initial ideas of meaning (Creswell, 
2003), in this case, “lack of resources” as a reason for non-adherence became a consistent 
idea presented during responses.  Therefore, when the data became repetitive and no new, 
significant, contributions were being made to ideas of meaning, data collection concluded 
(Dey, 2004).  When data collection concluded for the open-ended questions, 38 people 
had been asked the two open-ended questions.  Data were analyzed using a thematic 
development approach, including discovering themes and subthemes from the text 
gathered during the interviews, condensing the data to a manageable amount of themes 
and placing themes in a hierarchy (Ryan & Bernard, 2003).  Initially, data were looked at 
as a whole.  All responses were read by the researcher, in an attempt to reflect on the 
larger meaning of the data (Creswell, 2003), and then a coding process began.  The data 
were organized into categories, labeling them with meaningful ideas, before actual 
themes emerged (Creswell, 2003).  Once this process took place with all the responses, 
the data were reviewed in light of the codes.  The codes and the meaningful ideas (notes) 
were taken together and reflected upon.  The final step was making an interpretation of 
the data, where the “lessons learned”, which captures the essence of interpretation 
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(Lincoln, 1985).  The interpretive process ended with emerging themes and subthemes.  
Finally, quotes from the original responses were used to support the themes. 
Sample Size 
To calculate adequate sample size for this study, several factors were considered.  
The first was anticipated effect size for a behavioral science research study.  Due to the 
lack of effect-size reporting and the minimal literature around this concept, rationale was 
drawn from Cohen (J. Cohen, 1992), who developed a standard for effect size (ES) that 
remains somewhat consistent among indexes in psychological research.  He refers to 
these effect sizes as small, medium, and large, where medium ES is large enough to be 
observed by the naked eye, and is generally accepted as the average ES across various 
fields.  Because social and behavioral sciences often neglect to report effect size values, 
using Cohen’s recommendation has added some consistency in the literature (J. Cohen, 
1992).  In similar studies that examined decision-making for persons with SMI, effect 
size was reported to be from .17 (O'Neal et al., 2008) to .20 (Puschner et al., 2010).  For 
this study, a medium effect size of .15 (multiple regression analysis) was used based on 
Cohen’s rationale and related literature.  Power level was set at .80 and significance level 
was set at .05. 
 Using G-Power (Erdfelder, Faul, & Buchner, 1996), a software program for 
determining sample size for an a priori power analysis, the required sample size for 
medium effect size of .15, with an alpha of .05, a power of .80, and 8 predictors, using 
hierarchical multiple linear regression was 109.  The sample size obtained for this study 
was 95, and given the same parameters for effect size and alpha, it revealed a resulting 
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power of .79 for hypothesis 1.  For hypothesis 2, the sample size was 56 and the resulting 
power was .43. 
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Chapter 4: RESULTS   
Background of Study Participants 
 Participants for this study were 95 adults with severe mental illness attending a 
primary care clinic (integrated into a community mental health center) for their physical 
healthcare needs.  Ninety-seven patients from the clinic were recruited, but two were 
unable to pass the consent quiz, and therefore did not complete Time 1 measures.  As 
seen in Table 3, participants were mostly Caucasian (93.7%) and males were slightly 
more represented (51.6%).  The average age of participants was 46.2 years.  Forty-two 
percent of the sample had a schizophrenia spectrum diagnosis as their primary mental 
health issue, with 22.1% having a primary diagnosis as bipolar disorder and 20% having 
major depression.  For physical health diagnoses, a third (32.6%) of the sample had 
hypertension, with 13.7% having hypertension as their primary diagnosis.  Obesity was 
also diagnosed for nearly a third (29.9%) of the sample, with 17.9% having obesity as 
their primary diagnosis.  Lung diseases (e.g. COPD, asthma) accounted for 26.3% of the 
sample, with 16.8% of the sample having a lung disease as a primary diagnosis.  Eighteen 
percent of the sample had diabetes, with 10.5% having diabetes as their primary 
diagnosis.  Average length of time participants had been attending the clinic was 7.2 
months.  
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Table 3.   
Study Sample Background Characteristics (N=95) 
Demographic Frequency (%)   Mean (SD) Range 
    
Sex 
Male 
Female 
 
49 (51.6%) 
46 (48.4%) 
  
    
Age  46.2 (12.4) 22-82 
    
Ethnicity 
American Indian/Alaskan Native 
African American 
  
 1 (1.1%) 
 4 (4.2%) 
  
Caucasian 
Other 
89 (93.7%) 
 4 (4.2%) 
  
    
Race    
Hispanic   4 (4.2%)   
Not Hispanic 91 (91.8%)   
    
Primary Mental Health Diagnosis  
Schizophrenia 40 (42.1%) 
Bipolar 21 (22.1%) 
Depression 19 (20.0%) 
Other 15 (15.8%) 
  
Secondary Mental Health Diagnosis  
Personality Disorder   5 (5.6%) 
Alcohol Dependence   3 (3.2%) 
Polysubstance Dependence   4 (4.2%) 
    
Primary Physical Health Diagnosis    
Obesity 17 (17.9%)   
Lung Diseases 16 (16.8%)   
Hypertension 13 (13.7%)   
Diabetes 10 (10.5%)   
Other * 39 (41%)   
    
Secondary Physical Health 
Diagnosis 
   
Obesity   7 (7.4%)   
Lung Diseases   2 (2.1%)   
Hypertension 14 (14.7%)   
Diabetes   3 (3.2%)   
    
Tertiary Physical Health Diagnosis    
Obesity   4 (4.2%)   
Lung Diseases   7 (7.4%)   
Hypertension   4 (4.2%)   
Diabetes   4 (4.2%)   
Months Attending Clinic  7.2 (7.0) 0-29 
*Other physical health diagnoses were varied could not be subsumed into new categories. 
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Table 4 provides an overall description of the types of social support.  Almost all 
participants (n=91) reported having some sort of social support.  Most reported that their 
social support was informal- coming from family and/or friends (n=81).  Only ten 
reported that their primary support came from formal support, namely mental health 
professionals such as case managers, and four reported no social support. 
Table 4. 
Types of Social Support (N=95) 
Type N % 
 
   
Informal 
Family 
Friends 
Neighbor 
AA Sponsor 
81 
70 
8 
2 
1 
 
73.7% 
8.4% 
2.1% 
1.1% 
   
Formal 
Mental Health 
Providers 
10 
 
10 
 
 
10.5% 
   
No Support 4 4.2% 
   
 
Of 95 participants, 56 completed the three-month follow up (Time 2) measures.  
In order to examine whether there were any significant differences between those who 
completed both Time 1 and 2 measures and those who completed only Time 1 measures, 
the key background and study variables were compared between these two groups.  Due 
to the small number of participants, response categories for some variables were 
collapsed for analysis.  Table 5 displays the results of these analyses. 
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Table 5. 
Differences between study completers and non-completers 
Variable Total (N=95) Completers 
(N=56) 
Non-Completers 
(N=39) 
t or χ2 P-value 
      
Age (years) (mean, SD) 46.2 (12.41) 43.2 (10.34) 48.32 (13.28) -2.01 .05* 
      
Sex (males, N, %), %) 49 (51.6%) 27 (48.2%) 22 (56.4%) .62 .43 
      
Mental health diagnosis    .80 .78 
Schizophrenia group (N, %)) 40 (41.2%) 17 (30.3%) 25 (64.1%)   
Depression group (N, %) 40 (41.2%) 17 (30.3%) 22 (56.4%)   
      
Physical Health Diagnosis    5.07 .28 
Obesity (N, %) 17 (17.9%) 30 (76.9%) 21 (37.5%)   
Lung diseases (N, %) 16 (16.8%)   8 (20.5%)   6 (10.7%)   
Hypertension (N, %) 13 (13.7%)   5 (12.8%)   8 (14.3%)   
Diabetes (N, %) 10 (10.5%)   7 (17.9%)   3 (5.4%)   
Other (N, %)2 39 (41%)   6 (10.7%)   1 (2.6%)   
      
Length of time at clinic 
(months, mean, SD) 
 4.90 (6.1) 8.82 (7.12) -2.80 .00*** 
      
Mental health severity 
(mean, SD) 
20.68 (12.48) 20.49 (12.39) 20.82 (12.65) -.13 .89 
      
Physical health severity 
(mean, SD) 
40.43 (13.77) 44.99 (12.94) 37.26 (13.54) 2.79 .00* 
      
Medication adherence 
Time 1 (mean, SD) 
2.66 (1.19) 2.67 (1.11) 2.66 (1.25) .024 .98 
      
Autonomy Preferences 
(mean, SD) 
42.02 (6.41) 42.08 (6.12) 41.98 (6.65) .07 .94 
      
Perceived Autonomy 
Support (mean, SD) 
36.01 (14.11) 38.13 (4.68) 34.57 (17.79) 1.20 .23 
*p<.05., ***p<001. 
 
 
 
 
 
 
 
60 
 
Study completers and non-completers were significantly different in age, length 
of time attending the clinic, and physical health severity (See Table 5).  Completers were 
younger, had significantly fewer months attending the clinic and had higher physical 
health severity than non-completers.  There were no significant differences for 
completers and non-completers on sex, mental and physical health diagnoses, mental 
health severity, autonomy preferences, perceived autonomy support, medication 
adherence and social support. 
Correlations 
Pearson r correlations were run between all the continuous independent variables 
and the dependent variables to identify the extent to which the independent variables 
were correlated with the dependent variables and with each other.  Table 6 displays these 
correlations.  The dependent variable for the first hypothesis, autonomy preferences for 
physical healthcare decision-making, had negative significant correlations with 
perception of autonomy support from physician (r= -.21, p< .05), and medication 
adherence at Time 2 (r= -.31, p<.05), and a positive correlation with being male (r=.34, 
p<.001).  In other words, reporting more desired autonomy was associated with being 
male and reporting lower levels of perceived support from their physician.  Correlation 
with appraisal of social support approached significance (r= -.19, p= .060).  The 
dependent variable for hypothesis 2, medication adherence at Time 2, had several 
significant correlations: autonomy preference (r= -.31, p<.05), age (r=.31, p<.05), 
perception of autonomy support (r=.30, p<.05), severity of mental health symptom       
(r= -.46, p<.01), and medication adherence at Time 1 (r=.62, p<.01).  In other words, 
patients who reported higher medication adherence at Time 2 were older, perceived more 
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autonomy support from their physician, and reported higher adherence at Time 1.  
Alternatively, participants who reported lower adherence at Time 2 desired more 
autonomy in their decision-making and had more severe mental health symptoms.
62 
 
Table 6.  
Correlations between variables. 
 1 2 3 4 5 6 7 8 9 10 11 12 
1) Autonomy 
    Preference 
1.00 .34** -.09 .06 -.21* -.19 .03 -.05 -.03 -.17 -.31* -.06 
2) Sex  1.00 -.06 .07 -.07 -.04 .01 -.21* .03 -.12 -.09 -.11 
3) Age   1.00 -.23* .04 -.07 -.20* -.13 -.16 .16 .31* .12 
4) Physical       
    Health 
    Severity 
   1.00 .21* .05 .27* .18 -.14 -.11 .20 -.09 
5) Autonomy 
    Support 
    1.00 .22* .11 .25* -.19 .20* .30* .16 
6) Social 
    Support 
   Appraisal 
     1.00 .65** .66** -.35* .26* .11 .18 
7) Social 
    Support 
   Assistance 
      1.00 .72** -.29** .09 .15 .19 
8) Social 
    Support 
    Belonging 
       1.00 -.35** .21* .18 .29** 
9) Mental 
    Health 
    Symptom 
        1.00 -.21* -.46** -.21* 
10) Med 
      Adherence 
      Time1 
         1.00 .62** .06 
11) Med 
      Adherence   
      Time 2 
          1.00 .17 
12) Months at 
      Clinic 
           1.00 
*p<.05;** p<.01.
63 
 
Model: Hypothesis 1 
 A multiple regression analysis was conducted to see how well the predictors of 
age, sex, mental health severity, perceived physical health severity, perceived social 
support, and length of time attending the clinic predicted physical health decision-making 
autonomy preferences. 
Initially, data were double-checked for multicollinearity by observing the 
tolerance and VIF values for the predictor variables.  According to Field (2009), 
tolerance values below .10 and VIF values above 10 indicate multicollinearity.  After the 
highly correlated social support variables of assistance and belonging were removed, 
none of the predictor variables had values that exceeded tolerance or VIF limits.  
Therefore, multicollinearity was not considered a threat.   
Table 7 displays the statistics for the regression model used for the first analysis.  
The six independent variables regressed on the dependent variable showed a significant 
overall model (F (6, 88) = 2.99, p<.01).  The predictor variables collectively accounted 
for 17% (R2=.17, p<.01) of the variance in the dependent variable of autonomy 
preferences, however, only two were significant.  The variables with the most predictive 
value according to their significance and beta weights were appraisal of social support 
(ISEL appraisal subscale) and sex.  Appraisal of social support had a negative 
relationship with the dependent variable, while being male had a positive relationship.  In 
other words, the more someone perceived that they had someone to talk to about their 
problems (appraisal of support), the less they desired autonomy in their physical health 
decision-making.  Additionally, males desired more physical healthcare decision-making 
autonomy than females.  These results do not support the original hypothesis that stated 
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women and people with higher levels of perceived social support would desire more 
autonomy in their physical health decision-making.  Other predictors such as older age 
and less severe physical and mental health symptoms did not significantly contribute to 
the model, and the low zero-order correlations suggest that they are not significant 
predictors of autonomy preferences.  
Table 7.  
Summary of Regression Analysis for Variables Predicting Physical Health Decision-
Making Autonomy Preferences (N=95)  
 
*p<.05. ** p<.01.  ***p<001. 
 
 
 
 
Variable B SE B β 
    
    
Age -.05 .05 -.11 
    
Sex (Male) 4.14 1.25 .33** 
    
Social support-
Appraisal  
-.21 .09 -.24* 
    
Mental health 
symptoms 
-.07 .06 -.14 
    
Physical Health 
Severity 
.00 .05 .01 
    
Months Attending 
Clinic 
.00 .09 .00 
    
R2  .17  
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Model: Hypothesis 2.   
Hierarchical multiple regression (HMR) was performed by entering the first block 
of predictor variables including age, sex, mental illness severity, perceived physical 
illness severity, perceived social support, and length of time attending clinic.  The second 
block included the predictors of perceived autonomy support from primary care physician 
and autonomy preferences. These predictors were regressed upon the dependent variable 
of medication adherence at Time 2, while the first block of predictors was held constant.  
Table 8 displays the statistics of the HMR.  The first model was significant, F (7, 49) 
=8.74, p<.001, and explained 55.5% of the variance.  When the predictors of support for 
decision-making autonomy and desired autonomy preferences were added, the model was 
significant F (9, 47) =6.77, p<.001 and explained 56.4% of variance.  However, adding 
the two additional predictors explained only additional .09% of variance and the increase 
was not significant F (2, 47) =.51, p=.61.  In the first model, the strongest predictor was 
medication adherence at Time 1 (β=.51, p<.001), then mental illness severity (β=-.33, 
p<.01), and physical health severity (β=.21, p<.05).  At Time 2, significant predictors 
were also medication adherence at Time 1 (β=.49, p<.001) and mental illness severity 
(β=-.35, p<.01), but physical health severity was not significant.  In other words, when 
the first block of predictors was held constant, those who had low adherence at time 1, 
had more severe mental health symptoms and reported lower adherence at time 2. 
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Table 8.  
Summary of Hierarchical Multiple Regression Analysis for Predictor Variables of 
Physical Health Decision-Making Autonomy Preferences (N=56) 
                       Model 1                          Model 2 
Variable B SE B β B SE B β 
Age .01 .01 .16 .01 .01 .14 
Sex -.03 .22 -.01 .06 .24 .03 
Social support: Appraisal -.02 .02 -.14 -.03 .02 -.18 
Mental illness severity    -.03      .01      -.33** -.03 .01 -.35** 
Physical health severity     .02      .01 .21*        .02        .01 .20 
Months at Clinic     .01      .02 .05        .01        .02 .05 
Time 1 Medication 
Adherence 
   .46   .01      .51***   .44   .01     .49*** 
Physician Autonomy 
Support 
          .00        .01      .04 
Autonomy Preference           -.02        .02     -.01 
R2   .56          .56 
*p<.05. ** p<.01.  ***p<001. 
 
Open-ended themes around medication adherence.    
During the Time 2 data collection, participants were asked about the barriers and 
facilitators to medication adherence for physical health care.  A thematic analysis 
revealed five major themes: behavior-related facilitators, personal support facilitators, 
resource barriers, and pharmacy-related facilitators and barriers.  Quotes from the 
participants are used to further evidence the themes. Table 9 displays the themes and sub-
themes. 
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Table 9. 
 Facilitators and Barriers to Physical Health Medication Adherence (N=38) 
Behavioral Facilitators (N=24) 
 Using a medication planner 
 Placing medications in a convenient and consistent area in the home  
 Synchronizing taking medications with an event (e.g. the evening newscast) 
Personal Support Facilitators (N=10) 
 Reminders from loved ones to take medications  
 Taking medications at the same time as loved ones 
Pharmacy-related Facilitators (N=8) 
 Medications are pre-packaged  
 Convenient access to the pharmacy 
 Pharmacy allows co-pays to be late 
Resource Barriers (N=16) 
 Not enough money to pay co-pays 
 Transportation issues getting to the pharmacy 
 Do not have the things they need to take meds consistently (e.g. alarm 
clock, medication planner) 
Pharmacy-related Barriers (N=4) 
 Medications are not filled correctly 
 Miscommunication between the doctor and the pharmacy  
 Prescriptions are sent electronically instead of written down 
 
 
Behavior-related facilitators.  The most cited facilitator was adopting behaviors that 
made adherence to their physical health medications easier.  Several participants reported 
that certain medication-taking behaviors aid in staying adherent.  These activities make it 
easier to remember, such as placing medications in a common area where they can be 
easily seen, syncing taking medications with another event throughout the day, or using a 
medication box/planner.  For example, one participant reported: “I only take my meds 
twice a day, and I eat twice a day, so I take my meds when I eat.”  Another stated: “I take 
my meds with the newscast.  The news is on in the morning, noon and at night, and that’s 
when I take them.”  Conveniently placing the medications also seemed to assist in taking 
them at the correct time.  For example, one participant stated: “My meds are prescribed at 
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bedtime, and I keep them there right next to my bed.”  Similarly, someone reported: “I 
only take one med in the morning, so I take it with my morning coffee and I keep it in the 
kitchen.”  Several people indicated that using a medication box helps.  One person stated: 
“I use a pill organizer and I take my meds at the exact same time every day.”  
Personal support facilitators.  Participants acknowledged that having family, friends or 
staff who assist them in various ways in taking their medications was an important 
facilitator.  Several stated that their loved ones use verbal reminders or cues to either take 
medications or to check and see if the medications were taken.  One participant noted: 
“My wife reminds me.  If she doesn’t remind me, I forget” and another stated: “My sister 
reminds me, she asks me if I’ve taken it.  She lives with me so she is always around.”   
One participant stated that a friend comes over and “reminds me, and helps me to set up 
my meds.”  Three participants said that their loved ones also take medications and that 
they synchronize.  One person noted: “My roommate helps me, she keeps them in one 
place, and when she takes hers, I take mine.” Another participant offered: “My husband 
takes his the same time I take mine, so we take them together.”   
Resource barriers.  The most frequently reported barrier to medication adherence was 
lack of resources.  Nine people stated that they have financial barriers to obtaining 
medications.  Several reported having to manipulate how they take their medications to 
make it stretch.  One participant noted: “Money plays an issue- some meds I only take 
once a day instead of twice a day, and sometimes I still run out before I can get more.”  
Another person reported that not having medical coverage is the problem, “Lack of 
insurance and money is a barrier, sometimes I run out [of meds] before I can get more.”  
There were other financial problems related to getting medications.  One person stated 
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that his mother was his payee and she would “forget to pay my pharmacy bill and it’s 
hard to access my medication when she hasn’t paid.”  Another participant offered that “I 
don’t always have the money for the co-pays…I have to pay the bills too.”  A respondent 
stated he “missed my morning doses often” because “I cannot wake up in the morning.”  
He stated he wanted to “buy an alarm clock” to help him wake up, but cannot because of 
not having enough money.  One person indicated that she “wants a med box, but doesn’t 
have the money to buy one.”  Similarly, five people reported that they do not have 
transportation to get their medications from the pharmacy.  One participant noted that 
after she pays her bills and co-pays, she often does not have money “for gas to get to the 
pharmacy.”  Others stated that they have trouble finding a ride. 
Pharmacy-related facilitators and barriers.  Several participants reported that factors 
related to the pharmacy they used helped or hindered medication adherence.  One helpful 
service reported was receiving medications pre-packaged from the pharmacy and 
therefore doses are automatically prepared.  One participant noted: “I couldn’t keep track 
of my meds if they weren’t pre-packaged.”  Another benefit was easy access to the 
pharmacy.  Three participants stated that living near the pharmacy helps to obtain 
medication, and two reported they use the “in-house pharmacy” at the mental health 
center and it is “convenient” to have it “right there.”  Lastly, one participant noted the 
benefit that the pharmacy understood her financial situation, and the “pharmacy allows 
me to pay my co-pays late, when I have the money.”  
Several participants reported pharmacy-related barriers.  Two stated that they had 
problems getting their medications filled properly, and one specifically said: “I switched 
pharmacies because of the problems I had with the in-house one.”  Additionally, one 
 
 
70 
 
participant spoke of preferring written prescriptions versus having them called-in by the 
doctor or nurse, because “sometimes the doctor’s office and the pharmacy get their wires 
crossed.” 
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Chapter 5: DISCUSSION 
Summary and Overview of Findings 
The first aim set forth in this study was to identify what factors predicted physical 
health decision-making autonomy preferences for people with SMI.  Data were gathered 
on the variables of sex, age, perceived social support, physical health severity, mental 
health severity, and length of time attending the clinic.  As discussed in the introduction, 
and further evidenced in the literature review, understanding people’s decision-making 
autonomy preferences could assist those providing primary care in advancing decision-
making styles that are compatible with those preferences (Street et al., 2012).  This 
compatibility could lead to a more engaged relationship between doctor and patient, and 
to improved adherence to prescribed treatment.  Therefore, a second aim in this study was 
to observe whether perceived decision-making autonomy support from a physician, and 
decision-making autonomy preferences, could predict medication adherence.   
For the first hypothesis, correlations and multiple regression were used to analyze 
the contribution of the six predictor variables on the dependent variable.  Pearson’s r 
correlations showed a significant relationship between the dependent variable autonomy 
preferences and sex.  Restated, males desired more autonomy in their physical healthcare 
decision-making.  In the multiple regression analysis, the predictors accounted for 17% of 
the variance.  There were two significant predictors, appraisal of social support (having 
someone to talk to about your problems), and sex.  In other words, the more participants 
perceived having someone to talk to about their problems, the less autonomy in decision-
making they desired.  Also, males desired more autonomy than females, consistent with 
the correlation result. 
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The a priori hypothesis stated that women would prefer more autonomy in their 
physical health decision-making.  According to the research on people with SMI and 
healthcare decision-making, women with SMI want a more active role in physical 
healthcare decision-making (Arora & McHorney, 2000), and those that take an active role 
in making their healthcare decisions prefer a shared decision-making approach from their 
physicians (Levinson et al., 2005).  Additionally, Dwight-Johnson and colleagues (2000) 
suggest that women with SMI prefer more healthcare decision-making autonomy than 
their male counterparts, including deciding forms of treatment.  Contrary to the literature, 
the original hypothesis that women prefer more autonomous decision-making was not 
supported.  Additional analyses looking at whether the women in this sample had less 
social support or more severe mental health symptoms did not reveal any more insight as 
to why they desired less autonomy.  Taking a closer look at the data in this sample could 
reveal some alternative explanations.  We previously highlighted the inverse relationship 
between social support and desired autonomy in decision-making: that those with 
someone to talk to about their problems desire less autonomy.  A subsequent question is: 
do women have more social support and therefore desire less autonomy in this sample?  
The literature provides evidence that women with SMI indeed do have more social 
support than men (S. E. Rogers et al., 2004; Thoits, 2011), however, current literature 
does not explore how the social support of women with SMI impacts desired autonomy in 
physical healthcare decision-making.  When further analyzing the data of this sample, it 
was discovered that there were no significant differences in appraisal of social support (t= 
.420, p=.68) or types of social support, (e.g. formal or informal), x2 (2, N=95) = 4.52, 
p=.10. between men and women.  Another explanation to consider is whether the women 
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in this sample had more severe mental illness.  The research elucidates that having more 
severe mental health symptoms is a factor in decision-making (Tan, 2009; Wong et al., 
2000).  It stands to reason that the sicker someone is, the less involved they are, or want 
to be, in making important healthcare decisions (Levinson et al., 2005).  However, in this 
sample, there were no differences in severity of mental illness symptoms (t=-.302, p= 
.76) for men and women.  Sex differences in decision-making autonomy preferences in 
physical healthcare should be further explored.  This data can be used as a foundation for 
more questions regarding the nature of this relationship. 
A theoretical explanation could be that women with SMI might feel less 
empowered than men to make healthcare decisions, so that they prefer less autonomous 
decision-making.  When reviewing the literature specifically highlighting empowerment 
in physical health decision-making for persons with SMI, there is evidence that suggests 
women with mental illness might have lower self-esteem, related to self-stigma, and 
therefore feel less empowered (Rüsch, Lieb, Bohus, & Corrigan, 2006).  This could be 
better explored in future research: exploring whether women with SMI feel empowered 
to make decisions, and what kinds of factors could contribute to increased empowerment. 
Those who perceived themselves as having someone to talk to about their 
troubles, which is defined as the appraisal of social support (S. E. Rogers et al., 2004), 
desired less autonomy in their physical health decision-making.  This was contrary to the 
hypothesis, which stated that the more social support someone had, the more autonomy 
they would desire.  The sample for this study reported a high amount of perceived social 
support, inconsistent with the literature which has previously reported that people with 
SMI have less perceived support (Kilbourne et al., 2007).  Of the participants perceiving 
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having social support, 84% reported having informal support (family, friends, AA 
sponsor, neighbor or pastor).  While appraisal of support was a significant predictor, the 
other two subscales of support (someone to provide practical help when needed) and 
belonging (feeling a part of a social group) did not predict desired autonomy in the 
regression analyses, and the correlations also showed near zero relationship with 
autonomy.   
If making physical healthcare decisions seems stressful or overwhelming, having 
someone to talk to could help someone feel as though they do not have to make the 
decision alone.  Assistance and belonging may not have similar applications in decision-
making and feelings of desired autonomy.  Assistance is having practical support (e.g. 
someone helping to provide transportation, money) and belonging is more of a social 
construct- belonging to a group of friends (S. E. Rogers et al., 2004).  If people who have 
someone to talk to desire less autonomy, it could be that they view their support system 
as co-decision makers, and that they do not have to make their decisions alone, and thus 
desire less autonomy. Another consideration is the formal support received by persons 
engaged in mental health services, and the decisions that may have been facilitated by 
their case managers, nurses and psychiatrists.  If their mental health team uses a more 
paternalistic approach in providing mental health services, specifically, the psychiatrist 
telling the client what medications to take, and the team making sure that medication 
regime is adhered to (Deegan & Drake, 2006), as opposed to a shared decision-making 
and patient-centered approach to care (Drake, 2010), the client might perceive primary 
care services in the same light.  The expectation might be that the decisions will be made 
for them. 
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For the second hypothesis, Pearson’s r correlation was used to observe the 
significant relationships of the predictor variables with the dependent variable, and 
hierarchical multiple regression was used to analyze the unique contribution of autonomy 
preferences and perceived autonomy support on the variance of medication adherence at 
Time 2.  Correlation analysis revealed that higher medication adherence at Time 2 was 
associated with being older, being adherent to medication at Time 1, perceiving physician 
support for their autonomy, desiring less decision-making autonomy, and having less 
severe mental health symptoms.  Although this study reveals that medication adherence 
increases with age, the literature reveals that non-adherence among people who are older 
with mental illness range from 45%-75% (Zivin & Kales, 2008).  However, these studies 
all refer to mental health medications.  Literature that reports adherence rates to physical 
health medications for older adults with mental illness is lacking in the literature.   
The literature also addresses the relationship between perceived autonomy 
support and medication adherence.  It seems likely that when a doctor supports a patient’s 
decision-making, the patient’s treatment adherence could increase.  This has been found 
in the general population, but not in the SMI literature.  Among patients with diabetes, it 
has been suggested that increased physician support improves their medication adherence 
(G.C. Williams et al., 1998), and it has even been offered that successful models of 
improving patient adherence include autonomy support (Delamater, 2006).  However, if 
the sample in this study desires less autonomy while being more adherent, it is possible 
that patients view medication taking through the lens of “compliance” (Deegan, 2007).  
In other words, instead of taking medications as a “choice”, patients might not feel 
autonomous, or desire autonomy, but instead, do what is expected of them.  They might 
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feel that they have the support of their physician for their autonomy as long as they are 
compliant with their treatment regime (Deegan & Drake, 2006). 
In the hierarchical regression model, when controlling for the background 
variables, decision-making autonomy preferences and perceived autonomy support from 
physician did not significantly predict medication adherence.  A major reason for the lack 
of findings for hypothesis 2 was the lack of adequate power for the study.  The Time 2 
sample size was small, as a result of loss to follow-up, which resulted in a power of .43 
for the second analysis. An underpowered study can fail to find significance even when it 
exists (Maxwell, 2004).  Another possible reason for lack of findings for hypothesis 2 is 
the large number of predictor variables compared to the sample size.  For the HMR 
analysis, nine predictor variables were used with a sample size of 56.   
Two variables from Time 1 measures were significant in predicting medication 
adherence in the regression analysis: medication adherence and mental health symptom 
severity.  It stands to reason that there would be some consistency in medication 
adherence at Time 1 and Time 2, as there were only three months in between measures, 
and that people’s medication-taking behavior may remain stable over short periods of 
time.  Also, similar to the correlational findings, higher adherence at Time 2 was 
predicted by less severe mental health symptoms.  Literature validates this finding, as 
symptoms can impact a person’s ability to adhere to their medication regime (J. Adams & 
Scott, 2000), and, symptoms are more likely to be less manageable with low adherence 
(Gray, Wykes, & Gournay, 2002).  This is substantiated in the literature regarding mental 
health medication adherence (Velligan et al., 2009), however, there is no literature base 
regarding physical health medication adherence for people with SMI.  This finding raises 
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the question: are people with severe mental illness, whose symptoms are more difficult to 
manage, equitably non-adherent to mental health and physical health medications, or are 
there differences?  In other words, do people perceive adhering to their mental health 
medications differently than their physical health medications?  And to what extent do 
exacerbated mental health symptoms impact this perception?   
The qualitative analysis provided some insight into what helps and hinders 
physical medication adherence for people with SMI.  The sample in this study cited the 
most helpful factor in taking physical healthcare medication consistently was having 
personal support.  Many participants stated that the verbal reminders from family or 
friends were the key factor to taking their medications on time and correctly.  
Additionally, several offered that they take their medications with their loved ones when 
they take their medications- in other words, like a buddy system.  These two open-ended 
questions asked about medications prescribed by their primary care physician, which 
would indicate their physical health medications.  However, it is possible that their habits 
in taking their physical health and mental health medications are similar.  It may have 
been more helpful to add a question about whether the participants perceived any 
differences in facilitators and barriers to adherence to physical health and mental health 
medications. 
The literature is clear regarding adherence issues for persons with SMI and their 
mental health medications. For example, participants stated that they wanted to have a 
voice in what kind of medication they took, which could increase adherence (Woltmann, 
2010) and that side-effects of mental health medications could influence whether or not 
people were adherent (Fleck, Keck, Corey, & Strakowski, 2005).  Lastly, studies of 
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adherence to mental health medications have shown that non-adherence could result from 
a perceived lack of need - either the persons feel like they are not ill and therefore, do not 
need to take the medications, or the medications are not helping (J. Adams & Scott, 
2000).  More exploration would need to be done with in-depth interviews or other 
research methods to observe the similarities and differences between patterns of 
adherence for physical and mental health medications.  In fact, it would be interesting to 
see if a person had to choose between medications, which they would purchase or take, 
and for what reasons.  Specifically, one of the major responses to barriers was resources.  
If resources were limited, and they could only afford certain medications, which would 
they purchase?  How would they make this decision?  We know that resources barriers 
have prevented people with SMI seeking primary care services, and that integrated care 
programs have improved accessibility (Druss, Rohrbaugh, Levinson, & Rosenheck, 
2001), however, that is only one piece of the larger puzzle of improved physical health 
outcomes for people with SMI.  If they have trouble accessing the very treatment 
prescribed by their primary care doctor, how effective can integrated care be on its own? 
Social workers in the mental health field have a unique opportunity to address this 
issue.  Working closely with consumers of mental health services that also have comorbid 
physical health issues, they can assist in extending the effectiveness of medical services 
by removing barriers to accessing medications.  They can also provide a line of 
communication between the physical health doctors and the patients.  When doctors are 
unaware of a patient’s resource limitations, they may not understand the complete picture 
of adherence issues.  This communication may allow the doctor, patient and social 
worker to operate as a team to help the person with SMI with goals of improved health.   
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Limitations of Study 
 Several limitations have already been presented in this chapter.  However, others 
are also noteworthy for mention.  A limitation when designing the study was the lack of 
literature in the area of physical health decision-making for persons with SMI.  Studies 
exist that have observed the relationships between similar factors and mental health 
decision-making, but the primary care setting has gone largely understudied to date.  This 
point also creates a strength of this study, in that it makes a contribution to a currently 
growing body of literature. 
 A limitation while conducting the study was the difficulty in recruiting 
participants in the clinic.  Patients of the primary care clinic at the mental health center 
were approached at the time of their appointment, and if they agreed to participate, the 
interview was conducted after the appointment was completed.  However, the physician 
consistently ran late, sometimes his appointments were an hour behind.  There were 
people who agreed to participate when approached, who could not stay for the interview 
due to running short on time.  Therefore, the IRB was amended to be able to conduct the 
interview before the appointment.  This did not always work, either, because people 
would often forget to come in early for the interview.  Another issue that impacted 
recruitment was the “no-show” rate.  The research staff would pull the morning schedule 
in order to see how many patients would be attending clinic that had not yet been 
recruited, and frequently, several did not come in to their appointment. 
Another limitation was the number of participants lost to follow-up at Time 2.  
Thirty-nine people did not respond for reasons such as declining to further participate, did 
not answer the phone after a month of attempts, or phone was disconnected.  Different 
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attempts to contact the participants might have resulted in more responses.  Mailing the 
follow-up questionnaire, or contacting their mental health case managers to track down 
participants may have produced more responses.  The follow-up period was short (three 
months) and only one month past the three month mark was allotted as a reasonable time 
for follow-up.  Study completers were younger and had significantly fewer months 
attending the clinic and had higher physical health severity than non-completers.  It is 
possible that as a new patient at the clinic, the patients felt participating in a survey about 
their physical healthcare might provide them another way to voice their opinions and 
ideas.  During the interviews, several participants would talk about their experiences as 
they answered the survey questions, indicating that they had more to say.  It is interesting 
to find out that those with higher physical health severity would be more willing to 
complete the study than those who had less severe physical illnesses.  It could be that 
those with more severe physical illness were more likely to be at home when the 
researcher called for follow-up, thus presenting more of an opportunity to be reached, and 
may have also been more likely to continue seeing the doctor- therefore, contact 
information would have been current and they may have accepted phone calls from the 
clinic, versus ignoring them. There were no significant differences for completers and 
non-completers on sex, mental and physical health diagnoses, mental health severity, 
medication adherence and social support. 
Finally, participants recruited were largely Caucasian (94%) and non-Hispanic 
(91%).  Therefore, the analysis could not include differences in groups based on race or 
ethnicity, as this was not a diverse group of participants.  This could be explained by the 
location of the clinic.  The clinic was located at a suburban site of the CMHC, which has 
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fewer non-White consumers, versus their downtown location.  The lack of ethnic and 
racial diversity was a limitation for this study, given the literature, which highlights the 
potential differences in decision-making preferences driven by varied cultural 
backgrounds. 
Implications for Social Work Practice 
 Social workers in mental health and a variety of medical settings could benefit 
from the findings of this study.  Mental health social workers often find themselves 
facilitating access to medical care with people with severe mental illness (Rees, Huby, 
McDade, & McKechnie, 2004).  If these social workers make assumptions based on what 
they have experienced from a mental health setting perspective, they could miss 
opportunities to empower their consumers toward more informed and autonomous 
physical healthcare decision-making.  This study suggests that there may be variables to 
consider when exploring how a person prefers to make their physical healthcare decisions 
(e.g. alone, with a doctor, with family).  Social workers can explore autonomy 
preferences with their consumers and in doing so, can encourage healthy decisions and 
treatment adherence.   
Additionally, the qualitative findings from this study could help mental health 
social workers understand some reasons persons with SMI are not adherent to 
medications.  Social workers might use motivational techniques and resource linkage to 
help their consumers become or stay adherent to physical health medications.  There 
could be a variety of simple fixes, such as helping someone to buy a medication planner 
or an alarm clock.  This study could also assist social workers in medical settings, not 
familiar with the autonomy preferences of people with SMI, appropriately meet their 
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needs.  For example, medical social workers could make more informed decisions when 
facilitating discharge planning from a hospital, as releasing someone with a week’s worth 
of medication samples and a written prescription might not help someone adhere in the 
long run.  Medical social workers might need to take extra steps in ensuring at-home 
support in taking medications, pharmacy access, and the removal of financial barriers, 
such as Medicaid coverage or monetary assistance with co-pays.  These findings also 
encourage exploring all these issues with consumers.  Regardless of the setting, social 
workers should assess a consumer’s desire to participate in decision-making for all forms 
of treatment, and should work with them on the best way to become informed on 
medications and treatment options.   
 Social workers can also use this information to pursue conversations with 
physicians about how to best serve people with SMI.  Some primary care and other 
medical doctors approach treatment decision-making from a paternalistic, “what I say 
goes, because I’m the expert” style.  However, our study suggests that people with SMI 
have different autonomy preferences in decision-making.  Social workers can intervene 
with physicians, helping bridge the communication gap between doctor and patient.   
 This study revealed a significant relationship between autonomy preferences and 
having someone to talk with about problems (appraisal of support), that is, when 
someone perceives having others to talk to, they have less desired autonomy.  This could 
mean that when people feel they have someone they can discuss their problems with, they 
may be used to making decisions in consultation with others, they may also feel 
comfortable talking and making decisions with their doctors.  This could encourage a 
shared decision-making approach.  Therefore, it may benefit social workers to identify 
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whether people with SMI have someone to talk to about their problems, and engage 
support systems in the medical decision-making process.  If a consumer having someone 
to talk to means they desire less autonomy, perhaps they perceive needing someone to 
talk to in order to make decisions.  Therefore, it may be important for social workers to 
assist consumers in building their support networks if none or very little support is 
present.  However, this is only one way of interpreting the data.  It is also possible that 
having someone to talk to about healthcare problems means that the support person is 
relied upon to be the decision-maker.  Desiring less autonomy could result in depending 
on others to make the decisions, instead of making the decision oneself.  In this case, the 
patient may want the physician to make the entire decision.  Because the literature 
suggests that people with SMI desire a shared decision-making approach to healthcare (J. 
R. Adams et al., 2007), it is essential for social workers to assess these autonomy 
preferences and empower consumers toward increasing autonomy. 
Implications for Future Research 
 The limitations of this study prohibited generalization and explanations of the 
phenomenon discussed.  This study took a more exploratory approach.  A larger sample 
with a longer time allowance for follow-up could help to determine patterns in people’s 
decision-making and medication adherence.  Observing other treatment outcomes, other 
than medication adherence, would also be important, for example, following a diabetic or 
heart-healthy diet.  Understanding these patterns could better facilitate social workers’ 
ability to support long-term health and positive treatment habits.  However, this study 
does lay the foundation that relationships exist between factors such as sex, social 
support, and physical health decision-making autonomy preferences.  This study also 
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points to more questions that could continue to guide research in the fields of mental 
health, physical health, and integrated care, questions such as “what kind of social 
support best facilitates medication adherence?” and “what kinds of facilitators and 
barriers exist to adhering to physical health treatment other than medication?”  
Additionally, consistent with previous literature, the most common physical illnesses 
among people with SMI in this study are obesity, lung diseases, hypertension and 
diabetes.  Future research could identify specific disease-related issues, for example, what 
helps a person with SMI who has brittle diabetes successfully adhere to their insulin 
injections. 
 This study also highlighted a correlation between perception of autonomy support 
from the physician and medication adherence.  To continue to explore this relationship, 
other variables, such as returning to appointments or follow-up on other doctor’s orders 
(e.g. going to the lab, getting x-rays), could be added to future studies as outcome 
variables, strengthening the importance of supporting a person’s autonomy.  Primary care 
and other medical physicians may feel inhibited in their relationships with people with 
SMI and might make decisions for them, as opposed to engaging them toward shared 
decision-making.  Therefore, more work should be done to explore this relationship and 
the effect on the health behavior of persons with SMI.  Future research could look at this 
process- how engaging patients with SMI in their decision-making autonomy preferences 
in primary care influences the doctor-patient relationship, as well as health behaviors, 
such as wellness activities. 
 The Time 1 variables were not reassessed at Time 2.  Therefore, it was not 
possible to observe any change in the three month interval on any of the key predictor 
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variables, such as physical or mental health severity, or social support.  Changes in these 
variables could have changed the outcome of the study.  If this study were to be 
replicated, it might be wise to re-evaluate these variables again at Time 2. 
Conclusion 
 Although this study has a number of limitations, it contributes to a very limited 
literature base on the needs of people with SMI in primary care, and more narrowly, how 
certain factors can influence a person’s decision-making autonomy preferences.  More 
information about the relationship of these factors can assist social workers, physicians 
and family members in empowering those with SMI toward participation in their 
healthcare decision-making, increased autonomy in making choices that they feel are best 
for them and their lifestyles, and increased medication adherence.  There is a long way to 
go in uncovering what the most important factors are in decreasing the morbidity and 
mortality for persons with SMI, and this study explored only a couple of smaller angles. 
It is critical that research funding be earmarked to unravel the mystery of how to increase 
the wellness and longevity of people with severe mental illness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
REFERENCES 
Adams, J., & Scott, J. (2000). Predicting medication adherence in severe mental 
disorders. Acta Psychiatrica Scandinavica, 101(2), 119-124. doi: 10.1034/j.1600-
0447.2000.90061.x 
Adams, J. R., Drake, R. E., & Wolford, G. L. (2007). Shared Decision-Making 
Preferences of People With Severe Mental Illness. Psychiatric Services, 58(9), 
1219-1221. doi: 10.1176/appi.ps.58.9.1219 
Appelbaum, P. S. (2007). Assessment of Patients' Competence to Consent to Treatment. 
New England Journal of Medicine, 357(18), 1834-1840. doi: 
doi:10.1056/NEJMcp074045 
Arora, N. K., & McHorney, C. A. (2000). Patient Preferences for Medical Decision 
Making: Who Really Wants to Participate? Medical Care, 38(3), 335-341.  
Balint, M. (1957). The Doctor, the Patient, and His Illness. London, U.K.: Tavistock. 
Bates, J. A., Whitehead, R., Bolge, S. C., & Kim, E. (2010). Correlates of medication 
adherence among patients with bipolar disorder: results of the bipolar evaluation 
of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. 
Prim Care Companion J Clin Psychiatry, 12(5). doi: 10.4088/PCC.09m00883yel 
Bond, G. R., McGrew, J., & Fekete, D. (1995). Assertive outreach for frequent users of 
psychiatric hospitals: a meta-analysis. J Ment Health Adm, 22, 4 - 16.  
Bond, G. R., Salyers, M. P., Rollins, A. L., Rapp, C. A., & Zipple, A. M. (2004). How 
Evidence-Based Practices Contribute to Community Integration. Community 
Mental Health Journal, 40(6), 569-588. doi: 10.1007/s10597-004-6130-8 
 
 
87 
 
Borba, C. P. C., DePadilla, L., McCarty, F. A., von Esenwein, S. A., Druss, B. G., & 
Sterk, C. E. (2012). A Qualitative Study Examining the Perceived Barriers and 
Facilitators to Medical Healthcare Services among Women with a Serious Mental 
Illness. Women's Health Issues, 22(2), e217-e224. doi: 
http://dx.doi.org/10.1016/j.whi.2011.10.001 
Bosworth, H. B., Oddone, E. Z., & Weinberger, M. (2008). Patient Treatment 
Adherence: Concepts, Interventions and Measurement. Mahwah, NJ: Lawrence 
Earlbaum Associates, Inc. 
Bowden, J. A., Miller, C. L., & Hiller, J. E. (2011). Smoking and mental illness: a 
population study in South Australia. Australian and New Zealand Journal of 
Psychiatry, 45(4), 325-331. doi: doi:10.3109/00048674.2010.536904 
Brody, D., Miller, S., Lerman, C., Smith, D., & Caputo, G. (1989). Patient perception of 
involvement in medical care. Journal of General Internal Medicine, 4(6), 506-
511. doi: 10.1007/bf02599549 
Brown, C. H., Bennett, M. E., Li, L., & Bellack, A. S. (2011). Predictors of initiation and 
engagement in substance abuse treatment among individuals with co-occurring 
serious mental illness and substance use disorders. Addictive Behaviors, 36(5), 
439-447.  
Brown, S., Birtwistle, J., Roe, L., & Thompson, C. (1999). The unhealthy lifestyle of 
people with schizophrenia. Psychological Medicine, 29(03), 697-701.  
Buntin, M. B., Burke, M. F., Hoaglin, M. C., & Blumenthal, D. (2011). The Benefits Of 
Health Information Technology: A Review Of The Recent Literature Shows 
 
 
88 
 
Predominantly Positive Results. Health Affairs, 30(3), 464-471. doi: 
10.1377/hlthaff.2011.0178 
Burns, T., Fioritti, A., Holloway, F., Malm, U., & Rossler, W. (2001). Case Management 
and Assertive Community Treatment in Europe. Psychiatr Serv, 52, 631 - 636.  
Butler, M., Kane, R.L., McAlpine, D., et al. (2008). Integration of Mental 
Health/Substance Abuse and Primary Care. Evidence Reports/Technology 
Assessments. Rockville, M.D.: Agency for Healthcare Research and Quality. 
Casey, D. E., Haupt, D.W., Newomer, J.W., Henderson, David C., Sernyak, M.J., 
Davidson, M., et al. . (2004). Antipsychotic-induced weight gain and metabolic 
abnormalities: Implications for increased mortality for patients with 
schizophrenia. Journal of Clinical Psychiatry, 65(supp 7), 4-18.  
Chan, D. K.-C., Hagger, M. S., & Spray, C. M. (2011). Treatment motivation for 
rehabilitation after a sport injury: Application of the trans-contextual model. 
Psychology of Sport and Exercise, 12(2), 83-92.  
Chiu, M., Ho, W., Lo, W., & Yiu, M. (2010). Operationalization of the SAMHSA model 
of recovery: a quality of life perspective. Quality of Life Research, 19(1), 1-13. 
doi: 10.1007/s11136-009-9555-2 
Clark, R. E. (2001). Family Support and Substance Use Outcomes for Persons With 
Mental Illness and Substance Use Disorders. Schizophrenia Bulletin, 27(1), 93-
101.  
Clayton, M. F., Latimer, S., Dunn, T. W., & Haas, L. (2011). Assessing patient-centered 
communication in a family practice setting: How do we measure it, and whose 
 
 
89 
 
opinion matters? Patient education and counseling, 84(3), 294-302. doi: 
10.1016/j.pec.2011.05.027 
Clever, S. L., Ford, D. E., Rubenstein, L. V., Rost, K. M., Meredith, L. S., Sherbourne, C. 
D., . . . Cooper, L. A. (2006). Primary Care Patients' Involvement in Decision-
Making Is Associated With Improvement in Depression. Medical Care, 44(5), 
398-405 310.1097/1001.mlr.0000208117.0000215531.da.  
CMS, C. f. M. a. M. S. (2011). Medicare Covers Screening and Counseling for Obesity. 
from 
http://www.cms.gov/apps/media/press/release.asp?Counter=4189&intNumPerPag
e=10&checkDate=&checkKey=&srchType=1&numDays=3500&sr 
Cohen, J. (1992). A Power Primer. Psychological Bulletin, 112(1), 155-159.  
Cohen, S., & Wills, T. A. (1985). Stress, social support, and the buffering hypothesis. 
Psychological Bulletin, 98(2), 310-357. doi: 10.1037/0033-2909.98.2.310 
Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004). 
Characterizing coronary heart disease risk in chronic schizophrenia: High 
prevalence of the metabolic syndrome. The Canadian Journal of Psychiatry, 
49(11), 753-760.  
Conrad, K. J., Yagelka, J. R., Matters, M. D., Rich, A. R., Williams, V., & Buchanan, M. 
(2001). Reliability and Validity of a Modified Colorado Symptom Index in a 
National Homeless Sample. Mental Health Services Research, 3(3), 141-153. doi: 
10.1023/a:1011571531303 
Creswell, J. W. (2003). Research Design: Qualitative, Quantitative, and Mixed Method 
Approaches. Thousand Oaks, CA: Sage. 
 
 
90 
 
Croft, B., & Parrish, S. (2012). Care Integration in the Patient Protection and Affordable 
Care Act: Implications for Behavioral Health. Administration and Policy in 
Mental Health.  
Cummings, S. M. K., N.P. (2009). Formal and informal support for older adults with 
severe mental illness. Aging and Mental Health, 13(4), 619-627.  
Daumit, G., Cooper, L., Ford, D., & Stenwachs, D. (2002). How do individuals with 
severe mental illness rate the participatory decision-making styles of their primary 
care physicians? Abstracts of the Academy of Health Services Research 19(6).  
De Hert, M., Schreurs, V., Vancampfort, D., & Van Winkel, R. (2009). Metabolic 
syndrome in people with schizophrenia: a review. World Psychiatry, 8(1), 15-22. 
doi: 10.1002/j.2051-5545.2009.tb00199.x 
Deakin, B., Ferrier, N., Holt, R. I., Millar, H., Nutt, D. J., Reynolds, G., . . . Taylor, D. 
(2010). The physical health challenges in patients with severe mental illness: 
cardiovascular and metabolic risks. Journal of Psychopharmacology, 24(1 suppl), 
1-8. doi: 10.1177/1359786810374863 
Deegan, P. (2007). The lived experience of using psychiatric medication in the recovery 
process and a shared decision-making program to support it. Psychiatric 
Rehabilitation Journal, 31(1), 62-69.  
Deegan, P., & Drake, R. E. (2006). Shared Decision Making and Medication 
Management in the Recovery Process. Psychiatr Serv, 57(11), 1636-1639. doi: 
10.1176/appi.ps.57.11.1636 
Delamater, A. M. (2006). Improving Patient Adherence. Clinical Diabetes, 24(2), 71-77. 
doi: 10.2337/diaclin.24.2.71 
 
 
91 
 
Dey, I. (2004). Grounded Theory Qualitative Research Practice. London, U.K.: Sage. 
Dickerson, F. B., Brown, C. H., Kreyenbuhl, J. A., Fang, L., Goldberg, R. W., 
Wohlheiter, K., & Dixon, L. B. (2006). Obesity among individuals with serious 
mental illness. Acta Psychiatrica Scandinavica, 113(4), 306-313. doi: 
10.1111/j.1600-0447.2005.00637.x 
Dickerson, F. B., McNary, S. W., Brown, C. H., Kreyenbuhl, J., Goldberg, R. W., & 
Dixon, L. B. (2003). Somatic Healthcare Utilization Among Adults With Serious 
Mental Illness Who Are Receiving Community Psychiatric Services. Medical 
Care, 41(4), 560-570.  
DiMatteo, R. M. (2004). Social support and patient adherence to medical treatment: A 
meta-analysis. Health Psychology, 23(2), 207-218.  
DiMatteo, R. M., Haskard, K. B., & Williams, S. L. (2007). Health Beliefs, Disease 
Severity, and Patient Adherence: A Meta-Analysis. Medical Care, 45(6), 521-528 
510.1097/MLR.1090b1013e318032937e.  
DiNitto, D. M. J., D.H. (2012). Essentials of Social Welfare: Politics and Public Policy. 
Boston, MA: Pearson. 
Drake, R. E., Deegan, P.E., Rapp, C. . (2010). The promise of shared decision making in 
mental health. Psychiatric Rehabilitation Journal, 34(1), 7-13.  
Druss, B. G. (2007). Improving medical care for persons with serious mental illness: 
Challenges and solutions. Journal of Clinical Psychiatry, 68(7, supp 4.), 40-44.  
Druss, B. G., & Bornemann, T. H. (2010). Improving Health and Health Care for Persons 
With Serious Mental Illness. JAMA: The Journal of the American Medical 
Association, 303(19), 1972-1973. doi: 10.1001/jama.2010.615 
 
 
92 
 
Druss, B. G., Rohrbaugh, R. M., Levinson, C. M., & Rosenheck, R. A. (2001). Integrated 
Medical Care for Patients With Serious Psychiatric Illness: A Randomized Trial. 
Arch Gen Psychiatry, 58(9), 861-868. doi: 10.1001/archpsyc.58.9.861 
Dwight-Johnson, M., Sherbourne, C. D., Liao, D., & Wells, K. B. (2000). Treatment 
Preferences Among Depressed Primary Care Patients. Journal of General Internal 
Medicine, 15(8), 527-534. doi: 10.1046/j.1525-1497.2000.08035.x 
Ende, J., Kazis, L., Ash, A., & Moskowitz, M. (1989). Measuring patients’ desire for 
autonomy. Journal of General Internal Medicine, 4(1), 23-30. doi: 
10.1007/bf02596485 
Entwistle, V., & Watt, I. (2006). Patient involvement in treatment decision-making: the 
case for a broader conceptual framework. Patient Educ Counsel, 63, 268 - 278.  
Erdfelder, E., Faul, F., & Buchner, A. (1996). GPOWER: A general power analysis 
program. Behavior Research Methods, 28(1), 1-11. doi: 10.3758/bf03203630 
Ferron, J. C., Brunette, M. F., He, X., Xie, H., McHugo, G. J., & Drake, R. E. (2011). 
Course of Smoking and Quit Attempts Among Clients With Co-occurring Severe 
Mental Illness and Substance Use Disorders. Psychiatric Services, 62(4), 353-
359. doi: 10.1176/appi.ps.62.4.353 
Field, A. (2009). Discovering Statistics Using SPSS. London, U.K.: Sage. 
Fleck, D. E., Keck, P. E., Jr., Corey, K. B., & Strakowski, S. M. (2005). Factors 
associated with medication adherence in African American and white patients 
with bipolar disorder. J Clin Psychiatry, 66(5), 646-652.  
Fleishman, J. A., Selim, A. J., & Kazis, L. E. (2010). Deriving SF-12v2 physical and 
mental health summary scores: a comparison of different scoring algorithms. 
 
 
93 
 
Quality of life research : an international journal of quality of life aspects of 
treatment, care and rehabilitation, 19(2), 231-241.  
Freeman, E., and Yoe, J.T. (2006). The Poor Health Status of Consumers in Mental 
Healthcare: Behavioral Disorders and Chronic Disease. Paper presented at the 
Presentation to NASMHPD medical directors work group. 
Goff, D. C. (2007). Integrating general health care in private community pscyhiatry 
practice. Journal of Clinical Psychiatry, 68(7, Supplement 4), 49-54.  
Gray, R., Wykes, T., & Gournay, K. (2002). From compliance to concordance: a review 
of the literature on interventions to enhance compliance with antipsychotic 
medication. Journal of Psychiatric and Mental Health Nursing, 9(3), 277-284. 
doi: 10.1046/j.1365-2850.2002.00474.x 
Hamann, J., Cohen, R., Leucht, S., Busch, R., & Kissling, W. (2005). Do Patients With 
Schizophrenia Wish to Be Involved in Decisions About Their Medical Treatment? 
American Journal of  Psychiatry, 162(12), 2382-2384. doi: 
10.1176/appi.ajp.162.12.2382 
Hamann, J., Langer, B., Winkler, V., Busch, R., Cohen, R., Leucht, S., & Kissling, W. 
(2006a). Shared decision making for in-patients with schizophrenia. Acta 
Psychiatrica Scandinavica, 114(4), 265-273. doi: 10.1111/j.1600-
0447.2006.00798.x 
Hamann, J., Langer, B., Winkler, V., Busch, R., Cohen, R., Leucht, S., & Kissling, W. 
(2006b). Shared decision making for in-patients with schizophrenia. Acta Psych 
Scand, 114, 265 - 273.  
 
 
94 
 
Hamann, J., Mendel, R., Cohen, R., Heres, S., Ziegler, M., Buhner, M., & Kissling, W. 
(2009). Psychiatrists' Use of Shared Decision Making in the Treatment of 
Schizophrenia: Patient Characteristics and Decision Topics. Psychiatr Serv, 60(8), 
1107-1112. doi: 10.1176/appi.ps.60.8.1107 
Hasson-Ohayon, I., Levy, I., Kravetz, S., Vollanski-Narkis, A., & Roe, D. (2011). Insight 
into mental illness, self-stigma, and the family burden of parents of persons with a 
severe mental illness. Comprehensive Psychiatry, 52(1), 75-80.  
Heisler, M., Tierney, E., Ackermann, R. T., Tseng, C., Venkat Narayan, K. M., Crosson, 
J., . . . Kim, C. (2009). Physicians’ participatory decision-making and quality of 
diabetes care processes and outcomes: results from the triad study. Chronic 
Illness, 5(3), 165-176. doi: 10.1177/1742395309339258 
Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., 
& Stefaniak, M. (2004). Medication adherence in HIV-infected adults: effect of 
patient age, cognitive status, and substance abuse. AIDS, 18 Suppl 1, S19-25.  
Hochhauser, M. (2008). Consent Comprehension in the 21st Century: What is Missing? 
Drug Information Journal, 42(4), 375-384. doi: 10.1177/009286150804200410 
Horvitz-Lennon, M., Kilbourne, A. M., & Pincus, H. A. (2006). From Silos To Bridges: 
Meeting The General Health Care Needs Of Adults With Severe Mental Illnesses. 
Health Affairs, 25(3), 659-669. doi: 10.1377/hlthaff.25.3.659 
Hoving, C., Visser, A., Mullen, P. D., & van den Borne, B. (2010). A history of patient 
education by health professionals in Europe and North America: From authority 
to shared decision making education. Patient education and counseling, 78(3), 
275-281.  
 
 
95 
 
Howard, L. M., Barley, E. A., Davies, E., Rigg, A., Lempp, H., Rose, D., . . . Thornicroft, 
G. (2010). Cancer diagnosis in people with severe mental illness: practical and 
ethical issues. The Lancet Oncology, 11(8), 797-804.  
Hunot, V. M., Horne, R., Leese, M.N., & Churchill, R.C. (2007). A cohort study of 
adherence to antidepressants in primary care: The influence of antidepressant 
concerns and treatment preferences. Journal of Clinical Psychiatry, 9(2), 91-99.  
Hymowitz, N., Cummings, K. M., Hyland, A., Lynn, W. R., Pechacek, T. F., & Hartwell, 
T. D. (1997). Predictors of smoking cessation in a cohort of adult smokers 
followed for five years. Tobacco Control, 6(suppl 2), S57. doi: 
10.1136/tc.6.suppl_2.S57 
IOM. (2006). Improving the quality of health care for mental and substance-use 
conditions. Washington, D.C.: Institute of Medicine. 
Jones, D. R., Macias, C., Barreira, P. J., Fisher, W. H., Hargreaves, W. A., & Harding, C. 
M. (2004). Prevalence, Severity, and Co-occurrence of Chronic Physical Health 
Problems of Persons With Serious Mental Illness. Psychiatric Services, 55(11), 
1250-1257. doi: 10.1176/appi.ps.55.11.1250 
Kathol, R. G., Butler, M., McAlpine, D. D., & Kane, R. L. (2010). Barriers to physical 
and mental condition integrated service delivery. Psychosomatic medicine, 72(6), 
511-518.  
Katz, S. J., Lantz, P. M., Janz, N. K., Fagerlin, A., Schwartz, K., Liu, L., . . . Morrow, M. 
(2005). Patient Involvement in Surgery Treatment Decisions for Breast Cancer. 
Journal of Clinical Oncology, 23(24), 5526-5533. doi: 10.1200/jco.2005.06.217 
 
 
96 
 
Kilbourne, A., McCarthy, J., Post, E., Welsh, D., & Blow, F. (2007). Social support 
among veterans with serious mental illness. Social Psychiatry and Psychiatric 
Epidemiology, 42(8), 639-646. doi: 10.1007/s00127-007-0212-1 
King, J. S., Eckman, M. H., & Moulton, B. W. (2011). The Potential of Shared Decision 
Making to Reduce Health Disparities. The Journal of Law, Medicine & Ethics, 39, 
30-33. doi: 10.1111/j.1748-720X.2011.00561.x 
Kremer, H., Ironson, G., Schneiderman, N., & Hautzinger, M. (2007). ``It's My Body'': 
Does Patient Involvement in Decision Making Reduce Decisional Conflict? 
Medical Decision Making, 27(5), 522-532. doi: 10.1177/0272989x07306782 
Kreyenbuhl, J., Leith, J., Medoff, D. R., Fang, L., Dickerson, F. B., Brown, C. H., . . . 
Dixon, L. B. (2011). A comparison of adherence to hypoglycemic medications 
between Type 2 diabetes patients with and without serious mental illness. 
Psychiatry Research, 188(1), 109-114.  
Lambert, T. J., Velakoulis, D., & Pantelis, C. (2003). Medical comorbidity in 
schizophrenia. The Medical journal of Australia, 178 Suppl, S67-70.  
Lantz, P. M., Janz, N. K., Fagerlin, A., Schwartz, K., Liu, L., Lakhani, I., . . . Katz, S. J. 
(2005). Satisfaction with Surgery Outcomes and the Decision Process in a 
Population-Based Sample of Women with Breast Cancer. Health Services 
Research, 40(3), 745-768. doi: 10.1111/j.1475-6773.2005.00383.x 
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, 
D. H. (2000). Smoking and Mental Illness. JAMA: The Journal of the American 
Medical Association, 284(20), 2606-2610. doi: 10.1001/jama.284.20.2606 
 
 
97 
 
Lester, H., Tritter, J. Q., & Sorohan, H. (2005). Patients' and health professionals' views 
on primary care for people with serious mental illness: focus group study. BMJ, 
330(7500), 1122. doi: 10.1136/bmj.38440.418426.8F 
Levinson, W., Kao, A., Kuby, A., & Thisted, R. A. (2005). Not All Patients Want to 
Participate in Decision Making. Journal of General Internal Medicine, 20(6), 
531-535. doi: 10.1111/j.1525-1497.2005.04101.x 
Lincoln, Y. S. G., E.G. . (1985). Naturalistic Inquiry. Beverly Hills, CA: Sage. 
Loh, A., Simon, D., Wills, C. E., Kriston, L., Niebling, W., & Härter, M. (2007). The 
effects of a shared decision-making intervention in primary care of depression: A 
cluster-randomized controlled trial. Patient education and counseling, 67(3), 324-
332.  
Loukissa, D. A. (1995). Family burden in chronic mental illness: a review of research 
studies. Journal of Advanced Nursing, 21(2), 248-255. doi: 10.1111/j.1365-
2648.1995.tb02521.x 
Lutterman, T., Ganju, V., Schacht, L., Monihan, K. et al. . (2003). Sixteen State Study on 
Mental Health Performance Measures. Rockville, MD. 
Mauer, B. J. (2008). Behavioral Health/Primary Care Integration and the Person-Centered 
Healthcare Home. Washington, D.C.: The National Council for Community 
Behavioral Healthcare. 
Maxwell, S. E. (2004). The persistence of underpowered studies in psychological 
research: Causes, consequences, and remedies. Psychological Methods, 9(2), 147-
163.  
 
 
98 
 
McCabe, R., Heath, C., Burns, T., Priebe, S., & Skelton, J. (2002). Engagement of 
patients with psychosis in the consultation: conversation analytic study. Br Med J, 
325, 1148 - 1151.  
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: A Concise 
Overview of Incidence, Prevalence, and Mortality. Epidemiologic Reviews, 30(1), 
67-76. doi: 10.1093/epirev/mxn001 
Miller, B. J., Paschall, B. C., & Svendsen, D. P. (2006). Mortality and Medical 
Comorbidity Among Patients With Serious Mental Illness. Psychiatric Services, 
57(10), 1482-1487. doi: 10.1176/appi.ps.57.10.1482 
Miller, C. L., Druss, B. G., Dombrowski, E. A., & Rosenheck, R. A. (2003). Barriers to 
primary medical care among patients at a community mental health center. 
Psychiatric Services, 54(8), 1158-1161.  
Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive 
validity of a self-reported measure of medication adherence. Med Care, 24(1), 67-
74.  
Mueser, K. T., Bond, G. R., Drake, R. E., & Resnick, S. G. (1998). Models of 
Community Care for Severe Mental Illness: A Review of Research on Case 
Management. Schizophrenia Bulletin, 24(1), 37-74.  
NASMHPD. (2006). Morbidity and Mortality in People with Serious Mental Illness. In J. 
Parks, Svendsen, D., Singer, P., & Foti, M.E. (Ed.), Thirteenth in a Series of 
Technical Reports (pp. NASMHPD). Alexandria, VA. 
 
 
99 
 
NASW (Producer). (2008, 4/14/2011). Code of Ethics of the National Association of 
Social workers. Retrieved from 
http://www.socialworkers.org/pubs/code/default.asp 
Newcomer, J. W. (2007). Antipsychotic medications: Metabolic and cardiovascular risk. 
Journal of Clinical Psychiatry, 64(4), 8-13.  
Newcomer, J. W., & Hennekens, C. H. (2007). Severe Mental Illness and Risk of 
Cardiovascular Disease. JAMA: The Journal of the American Medical 
Association, 298(15), 1794-1796. doi: 10.1001/jama.298.15.1794 
NIMH (Producer). (2001, April 20, 2011). The numbers count: Mental disorders in 
America. Retrieved from http://www.nimh.nih.gov/statistics/index.shtml 
O'Neal, E. L., Adams, J. R., McHugo, G. J., Van Citters, A. D., Drake, R. E., & Bartels, 
S. J. (2008). Preferences of Older and Younger Adults With Serious Mental 
Illness for Involvement in Decision-Making in Medical and Psychiatric Settings. 
American Journal of Geriatric Psych, 16(10), 826-833 
810.1097/JGP.1090b1013e318181f318992.  
Okai, D., Owen, G., McGuire, H., Singh, S., Churchill, R., & Hotopff, M. (2007). Mental 
capacity in psychiatric patients: Systematic review. The British Journal of 
Psychiatry, 191(4), 291-297. doi: 10.1192/bjp.bp.106.035162 
Patel, M., Shilliday, I. R., & McKay, G. A. (2009). A combined diabetes renal clinic 
improves risk factor management and progression of renal disease in a district 
general hospital. Journal of Evaluation in Clinical Practice, 15(5), 832-835. doi: 
10.1111/j.1365-2753.2008.01097.x 
Payne, M. (2005). Modern Social Work Theory. Chicago, IL: Lyceum Books, Inc. 
 
 
100 
 
Pedhazur, E. J. (1997). Multiple Regression in Behavioral Research: Explanation and 
Prediction: Holt, Rinehart and Winston. 
Prins, M. A., Verhaak, P. F. M., Bensing, J. M., & van der Meer, K. (2008). Health 
beliefs and perceived need for mental health care of anxiety and depression—The 
patients' perspective explored. Clinical Psychology Review, 28(6), 1038-1058. 
doi: 10.1016/j.cpr.2008.02.009 
Puschner, B., Steffen, S., Slade, M., Kaliniecka, H., Maj, M., Fiorillo, A., . . . Becker, T. 
(2010). Clinical Decision Making and Outcome in Routine Care for People with 
Severe Mental Illness (CEDAR): Study protocol. BMC Psychiatry, 10(1), 90.  
Quisenaerts, C., Morrens, M., Hulstijn, W., Timmers, M., de Boer, P., Sabbe, B., & De 
Bruijn, E. R. A. (2013). Acute nicotine improves social decision-making in non-
smoking but not in smoking schizophrenia patients. Frontiers in Neuroscience, 7. 
doi: 10.3389/fnins.2013.00197 
Raue, P. J., Schulberg, H. C., Heo, M., Klimstra, S., & Bruce, M. L. (2009). Patients' 
Depression Treatment Preferences and Initiation, Adherence, and Outcome: A 
Randomized Primary Care Study. Psychiatr Serv, 60(3), 337-343. doi: 
10.1176/appi.ps.60.3.337 
Raue, P. J., Schulberg, H. C., Lewis-Fernandez, R., Boutin-Foster, C., Hoffman, A. S., & 
Bruce, M. L. (2010). Shared decision-making in the primary care treatment of 
late-life major depression: a needed new intervention? International Journal of 
Geriatric Psychiatry, 25(11), 1101-1111. doi: 10.1002/gps.2444 
Rees, G., Huby, G., McDade, L., & McKechnie, L. (2004). Joint working in community 
mental health teams: implementation of an integrated care pathway. Health & 
 
 
101 
 
Social Care in the Community, 12(6), 527-536. doi: 10.1111/j.1365-
2524.2004.00523.x 
Rogers, C. R. (1977). Carl Rogers on Personal Power. New York, NY.: Dell Publishers. 
Rogers, S. E., Anthony, W., & Lyass, A. (2004). The Nature and Dimensions of Social 
Support Among Individuals with Severe Mental Illnesses. Community Mental 
Health Journal, 40(5), 437-450. doi: 10.1023/B:COMH.0000040657.48759.0e 
Rowe, W. (1996). Social Work Treatment. In F. J. Turner (Ed.), (4th ed.). New York, 
NY: The Free Press. 
Rüsch, N., Lieb, K., Bohus, M., & Corrigan, P. W. (2006). Brief Reports: Self-Stigma, 
Empowerment, and Perceived Legitimacy of Discrimination Among Women 
With Mental Illness. Psychiatric Services, 57(3), 399-402. doi: 
10.1176/appi.ps.57.3.399 
Salyers, M. P., Bosworth, H. B., Swanson, J. W., Lamb-Pagone, J., & Osher, F. C. 
(2000). Reliability and Validity of the SF-12 Health Survey Among People With 
Severe Mental Illness. Medical Care, 38(11), 1141-1150.  
SAMHSA. (2008, April 20, 2011). 10 x 10 Wellness Campaign. from 
http://www.promoteacceptance.samhsa.gov/10by10/default.aspx 
Sandman, L., & Munthe, C. (2010). Shared Decision Making, Paternalism and Patient 
Choice. Health Care Analysis, 18(1), 60-84. doi: 10.1007/s10728-008-0108-6 
Say, R., Murtagh, M., & Thomson, R. (2006). Patients’ preference for involvement in 
medical decision making: A narrative review. Patient education and counseling, 
60(2), 102-114.  
 
 
102 
 
Schafer, W. D. (1991). Reporting hierarchical regression results. Measurement & 
Evaluation in Counseling & Development (American Counseling Association), 
24(3), 98.  
Scharf, D. M., Eberhart, N.K., Schmidt, N., Vaughan, C.A., Dutta, T., Pincus, H.A. & 
Burnam, M.A. (2013). Integrating Primary Care into Behavioral Health Settings: 
Programs and Early Implementation Experience. Psychiatric Services, 64(7).  
Scheibler, F., Janssen, C., & Pfaff, H. (2003). Shared decision making: an overview of 
international research literature. Soz Praventivmed, 48, 11-23.  
Shern, D., Lee, B., & Cohen, A. (1996). The Colorado Symptom Inventory: A self-report 
measure for psychiatric symptoms. Louis de la Parte Mental Health Institute. 
Tampa, FL.  
Silva, M., Markland, D., Minderico, C., Vieira, P., Castro, M., Coutinho, S., . . . Teixeira, 
P. (2008). A randomized controlled trial to evaluate self-determination theory for 
exercise adherence and weight control: rationale and intervention description. 
BMC Public Health, 8(1), 234.  
Simon, D., Loh, A., Wills, C. E., & Härter, M. (2007). Depressed patients’ perceptions of 
depression treatment decision-making. Health Expectations, 10(1), 62-74. doi: 
10.1111/j.1369-7625.2006.00424.x 
Sokal, J., Messias, E., Dickerson, F. B., Kreyenbuhl, J., Brown, C. H., Goldberg, R. W., 
& Dixon, L. B. (2004). Comorbidity of Medical Illnesses Among Adults With 
Serious Mental Illness Who Are Receiving Community Psychiatric Services. The 
Journal of Nervous and Mental Disease, 192(6), 421-427.  
 
 
103 
 
Stacey, D., Menard, P., Gaboury, I., Jacobsen, M., Sharif, F., Ritchie, L., & Bunn, H. 
(2008). Decision-making needs of patients with depression: a descriptive study. 
Journal of Psychiatric and Mental Health Nursing, 15(4), 287-295. doi: 
10.1111/j.1365-2850.2007.01224.x 
Street, R. L., Elwyn, G., & Epstein, R. M. (2012). Patient preferences and healthcare 
outcomes: an ecological perspective. Expert Review of Pharmacoeconomics & 
Outcomes Research, 12(2), 167-180. doi: 10.1586/erp.12.3 
Tai, B., Boyle, M., Ghitza, U., Kaplan, R.M., Clark, H.W., & Gersing, K. (2012). 
Meaningful use of electronic behavioral health data in primary health care. 
Science Translational Medicine(4), 119-123.  
Tan, J., Stewart, A. & Hope, T. (2009). Decision-Making as a Broader Concept. 
Philosophy, Psychiatry, & Psychology, 16(4), 345-349.  
Thames, A. D., Becker, B. W., Marcotte, T. D., Hines, L. J., Foley, J. M., Ramezani, A., . 
. . Hinkin, C. H. (2011). Depression, Cognition, and Self-Appraisal of Functional 
Abilities in HIV: An Examination of Subjective Appraisal Versus Objective 
Performance. The Clinical Neuropsychologist, 25(2), 224-243. doi: 
10.1080/13854046.2010.539577 
Thoits, P. A. (2011). Perceived Social Support and the Voluntary, Mixed, or Pressured 
Use of Mental Health Services. Society and Mental Health, 1(1), 4-19. doi: 
10.1177/2156869310392793 
Travis, L. A., Lyness, J. M., Shields, C. G., King, D. A., & Cox, C. (2004). Social 
Support, Depression, and Functional Disability in Older Adult Primary-Care 
Patients. American Journal of Geriatric Psych, 12(3), 265-271.  
 
 
104 
 
Turner, B. J., Laine, C., Cosler, L., & Hauck, W. W. (2003). Relationship of Gender, 
Depression, and Health Care Delivery With Antiretroviral Adherence in HIV-
infected Drug Users. Journal of General Internal Medicine, 18(4), 248-257. doi: 
10.1046/j.1525-1497.2003.20122.x 
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., & 
Docherty, J. P. (2009). The expert consensus guideline series: adherence problems 
in patients with serious and persistent mental illness. J Clin Psychiatry, 70 Suppl 
4, 1-46; quiz 47-48.  
Vogel, B. A., Leonhart, R., & Helmes, A. W. (2009). Communication matters: The 
impact of communication and participation in decision making on breast cancer 
patients’ depression and quality of life. Patient education and counseling, 77(3), 
391-397.  
Ware, J. E. J., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health 
Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. 
Medical Care, 34(3), 220-233.  
Ware, J. E. J., & Sherbourne, C. D. (1992). The MOS 36-ltem Short-Form Health Survey 
(SF-36): I. Conceptual Framework and Item Selection. Medical Care, 30(6), 473-
483.  
Weiss, S. J., Haber, J., Horowitz, J. A., Stuart, G. W., & Wolfe, B. (2009). The 
Inextricable Nature of Mental and Physical Health: Implications for Integrative 
Care. Journal of the American Psychiatric Nurses Association, 15(6), 371-382. 
doi: 10.1177/1078390309352513 
 
 
105 
 
Wilder, C. M., Elbogen, E. B., Moser, L. L., Swanson, J. W., & Swartz, M. S. (2010). 
Medication preferences and adherence among individuals with severe mental 
illness and psychiatric advance directives. Psychiatr Serv, 61(4), 380-385. doi: 
10.1176/appi.ps.61.4.380 
Williams, G. C., Freedman, Z. R., & Deci, E. L. (1998). Supporting Autonomy to 
Motivate Patients With Diabetes for Glucose Control. Diabetes Care, 21(10), 
1644-1651. doi: 10.2337/diacare.21.10.1644 
Williams, G. C., Grow, V. M., Freedman, Z. R., Ryan, R. M., & Deci, E. L. (1996). 
Motivational predictors of weight loss and weight loss maintenance. Journal of 
Personality and Social Psychology, 70(1), 115-126.  
Williams, G. C., Lynch, M., Glasgow, R.E. (2007). Computer-assisted intervention 
improves patient-centered diabetes care by increasing autonomy support. Heath 
Psychology, 26(6), 728-734.  
Williams, G. C., McGregor, H., Sharp, D., Kouides, R. W., Lévesque, C. S., Ryan, R. M., 
& Deci, E. L. (2006). A Self-Determination Multiple Risk Intervention Trial to 
Improve Smokers' Health. Journal of General Internal Medicine, 21(12), 1288-
1294. doi: 10.1111/j.1525-1497.2006.00621.x 
Williams, G. C., Rodin, G. C., Ryan, R. M., Grolnick, W. S., & Deci, E. L. (1998). 
Autonomous regulation and long-term medication adherence in adult outpatients. 
Health Psychology, 17(3), 269-276.  
Woltmann, E. M. W., R. (2010). Shared Decision Making in Public Mental Healthcare: 
Perspectives from Consumers Living with Severe Mental Illness. Psychiatric 
Rehabilitation Journal, 34(1), 29-36.  
 
 
106 
 
Wong, J. G., Clare, I. C. H., Holland, A. J., Watson, P. C., & Gunn, M. (2000). The 
capacity of people with a 'mental disability' to make a health care decision. 
Psychological Medicine, 30(02), 295-306. doi: doi:null 
Xiong, G. L., Iosif, A. M., Bermudes, R. A., McCarron, R. M., & Hales, R. E. (2010). 
Preventive medical services use among community mental health patients with 
severe mental illness:the influence of gender and insurance coverage. Prim Care 
Companion J Clin Psychiatry, 12(5). doi: 10.4088/PCC.09m00927gre 
Young, H. N., Bell, R. A., Epstein, R. M., Feldman, M. D., & Kravitz, R. L. (2008). 
Physicians' Shared Decision-Making Behaviors in Depression Care. Arch Intern 
Med, 168(13), 1404-1408. doi: 10.1001/archinte.168.13.1404 
Zivin, K., & Kales, H. (2008). Adherence to Depression Treatment in Older Adults. 
Drugs & Aging, 25(7), 559-571. doi: 10.2165/00002512-200825070-00003 
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve 
medication adherence in schizophrenia. Am J Psychiatry, 159(10), 1653-1664.  
 
 
 
 
 
 
 
 
 
CURRICULUM VITAE 
 
Jennifer Wright-Berryman 
EDUCATION 
2014  Ph.D., Indiana University, Indianapolis, Indiana 
2002 Master of Social Work, Indiana University School of Social Work, 
Indianapolis, Indiana 
1996 Bachelor of Science, Speech and Hearing Sciences, Purdue University, 
West Lafayette, Indiana 
ACADEMIC APPOINTMENTS 
2014  University of Cincinnati, School of Social Work: Assistant Professor 
2013-2014 University of Cincinnati, Blue Ash College: Assistant Professor 
2011-2013 Indiana University School of Social Work: Associate Faculty 
2009-2010 Indiana University School of Social Work: Research Assistant 
Data entry, cleaning and analysis for Assertive Community Treatment 
(ACT) in Indiana.  Data entry, cleaning and analysis for Illness 
Management and Recovery (IMR).   
Program evaluation for IMR at Adult and Child Mental Health Center. 
2006-2008 Ivy Tech Community College: Adjunct Faculty 
2004-2005 Indiana University School of Social Work: Field Supervisor 
Supervised students in their field placements, coordinating their 
placement, providing clinical and administrative supervision, and assisting 
with needs during placement. 
PROFESSIONAL EXPERIENCE 
2005-2013 Adult and Child Mental Health Center, 
ACT Center of Indiana: Research Coordinator 
 Grant writing contribution 
 Program Evaluation 
 Research coordination, data collection and manuscript preparation 
 Funding proposals  
 Training  
 Consultation 
 
 
 
 
Current Projects 
 Qualitative Study on the Successful Factors that Contribute to Mental 
and Physical Health Recovery 
 Decision-Making Preferences in Physical Healthcare for Persons with 
SMI, Instrument Factor Analysis and other validation 
 
Funded Projects: 
 State Division of Mental Health and Addiction (DMHA) Illness 
Management and Recovery (Evaluator, Adult and Child Mental Health 
Center) 
 Primary Care Behavioral Healthcare Integration Health Information 
Technology (Evaluator, Adult and Child Mental Health Center) 
 Comparison of Fidelity Assessment Methods (Fidelity Assessor, 
Roudebush VAMC) 
 CommonGround/Shared Decision-Making (Implementation 
Coordinator, NIMH R34) 
 
Unfunded Projects: 
 IMR discharge secondary data (survey) analysis 
 Inside/Out: A social work service learning experience. Qualitative 
secondary data content analysis. 
 
Past Funded Projects: 
 IMR Web- consumer and clinician qualitative interviews of a 
computerized version of IMR.  Manuscript under review. Role: 
Research Assistant. 
 Indiana Phone Fidelity Comparison Methods.  Manuscript in 
publication. Role: Self-report fidelity assessor. 
 
ACT Center of Indiana: Consultant and Trainer 
 Consultation and training support for Assertive Community Treatment 
teams in Indiana 
 Fidelity assessment and reporting to State of Indiana 
 Team growth and goal achievement 
 State standard development and consultation 
 In agency crisis training and consultation 
 
 
 
 
 
 
Adult and Child Mental Health Center: Team Leader, Branigin Subacute 
Unit 
 Clinical and administrative supervision of thirteen mental health 
technicians 
 Training and consultation in agency for crisis interventions 
 Developed programs of recovery and coordinated recovery efforts 
using a client-centered approach, motivational interviewing and stages 
of change. 
 
1996-2005 Quinco Behavioral Health Systems: Lead Clinican, Clinical Supervisor, 
Crisis Clinician and State Hospital Liaison 
 Clinical supervision to case management team 
 Therapeutic, evidence-based interventions for outpatient  
 Oversight of State Operated Facility admissions and discharges and 
clinical supervision of community reintegration.   
 Development, including design and implementation of recovery group 
for young adults with severe mental illness group. 
 
AWARDS AND RECOGNITIONS 
April, 2010.  The Jerry Powers Spirit of Inquiry Award for Excellence in 
Research.  Received at the Annual PhD Spring Symposium (100th 
Anniversary), Indiana University School of Social Work, Indianapolis, IN. 
LICENSURES AND CERTIFICATIONS 
 Therapeutic Options Instructor, 2010-2013 
 Licensed Clinical Social Worker, 2005-present 
 Licensed Social Worker 2002-2005 
 Certified Online Instructor, 2006 
 Certified Crisis Prevention Trainer, 2006 
 MSW Field Instruction Certification, 2003, 2004 
 
PROFESSIONAL ORGANIZATIONS AND COMMITTEES 
2008-2009 Student representative for the Social Work PhD committee 
2000-2003 Staff representative to Stigmabusters, a consumer-led advocacy group 
2008-2009 Chair, Forensic Subcommittee, Adult and Child Mental Health Center 
1999-2006 National Association of Social Workers 
 
 
 
 
 
 
 
 
 
 
JOURNAL PUBLICATIONS 
 
Rollins, A. L., McGrew, J. H., Kukla, M., McGuire, A. B., Flanagan, M. E., Hunt, M. G., 
Leslie, D. L., Collins, L. A., Wright-Berryman, J. L., Hicks, L. J., & Salyers, M. P. 
(2014, under review).  Comparison of fidelity assessment methods:  Reliability and 
validity. Administration and Policy in Mental Health and Mental Health Services 
Research. 
 
Rollins, A.L., Wright-Berryman, J.L., Henry, N.H., Quash, A.M., Benbow, K., Bonfils, K.A.,
 Hedrick, H., Miller, A.P., Firmin, R., & Salyers, M.P. (2014, under review) Managing 
physical and mental health conditions: Consumer perspectives on integrated care. Journal 
of Social Service Research. 
 
Wright-Berryman, J.L., Salyers, M.P., O’Halloran, J.P., Diazoni, A. & Mueser, K.T.
 (2013).  Consumer and Provider Responses to a Computerized 
Version of the Illness Management and Recovery Program.  Psychiatric 
Rehabilitation Journal, 36, 4. 
 
McGrew, J., White, L., Stull, L., Wright-Berryman, J.L. (2013). A 
comparison of self-reported and phone-based fidelity for Assertive Community 
Treatment (ACT): A pilot study in Indiana. Psychiatric Services.  Psychiatric 
Services, 64, 3. 
 
Wright-Berryman, J., McGuire, A., & Salyers, M. (2012).  A review of consumer-provided 
services on Assertive Community Treatment and intensive case management 
teams: Implications for future research and practice. Journal of the American 
Psychiatric Nurses Association, 17, 1, 37-44. 
 
PROFESSIONAL PRESENTATIONS 
Wright-Berryman, J. (2012, April). Inside Out: A social work classroom service learning 
experience. Poster presentation at the 2012 PhD Spring Symposium, Indiana 
University School of Social Work. Indianapolis, Indiana. 
Wright-Berryman, J. (2011, April).  A review of consumer provided services on Assertive 
Community Treatment and intensive case management teams: Implications for 
future research and practice. Poster presentation at the 2011 PhD Spring 
Symposium, Indiana University School of Social work. Indianapolis, Indiana. 
Wright-Berryman, J. (2010, April). How do students’ attitudes toward serious mental     
illness affect their perceptions of help-seeking behavior for first episode 
psychosis? Poster presentation at the 2010 PhD Spring Symposium, Indiana 
University School of Social Work. Indianapolis, Indiana. 
 
 
 
Wright, J. (2009, June). Knowledge and Skills for Effective Work with Forensically-
Involved Consumers.  Presentation at the Assertive Community Treatment 
Conference, Washington, D.C. 
Wright, J. (2009, April).   Leaving Prison with Serious Mental Illness: A Case Study.  A 
poster presented at the PhD Spring Symposium, IU School of Social Work.  
Indianapolis, Indiana. 
Wright, J. (2009, April). Leaving Prison with Serious Mental Illness: A Case Study.  A 
paper presented at the Mental Health in Corrections Conference, Kansas City, 
Missouri. 
Wright, J. (2008, June).  Stages of Change and Treatment. Presentation at the National 
Mental Health Conference:  Managing Mental Health from Corrections to 
Community, Indiana Department of Correction, Indianapolis, Indiana. 
Wright, J.  (2008, May).  Knowledge and Skills for Work with Forensic Consumers.  
Presentation at the Assertive Community Treatment Conference, ACT 
Association, Indianapolis, Indiana. 
Wright, J. (2004).  Strengths-Based Case Planning. Presentation at the Bartholomew 
County Probation Department. Columbus, Indiana. 
Wright, J. , Bauermeister, K., & Beam, J. (2004). Working Effectively with Transitional 
Age Youth.  Presentation at the Quinco Leadership Academy.  Columbus, Indiana. 
PROFESSIONAL DEVELOPMENT 
Conferences and Workshops Attended  
Structral Equation Modeling (August 2012). Gregory Hancock, University of Maryland. 
Indiana University Purdue University Indianapolis. 
Therapeutic Options Instructor Certification Training (October 2010). Therapeutic 
Options, Inc., Philadelphia, Pennsylvania. 
Mental Health Recovery: Practice, Services and Research. (October, 2010). New York 
University, New York City, New York. 
ACTA National Conference. (June 2009).  The Assertive Community Treatment 
Association National Conference.  Washington, D.C. 
National Mental Health in Corrections Conference. (July 2008).  Indiana Department of 
Corrections.  Indianapolis, IN. 
ACTA National Conference. (June 2008).  The Assertive Community Treatment 
Association National Conference.  Indianapolis, IN. 
 
 
 
Mental Health in Corrections Conference. (April 2008).  Forest Institute of Pscychology.  
St. Louis, MS. 
Person-Centered Planning Train the Trainer. (June, 2007).  Central Indiana Mental 
Health Initiative on Person-Centered Treatment Planning with National Trainers and 
Authors Neil Adams and Diane Grieder. Indianapolis, IN. 
ACTA National Conference.  (May 2007).  Assertive Community Treatment Association 
National Conference.  Grand Rapids, MI. 
Crisis Prevention Institute Train the Trainer. (August, 2006).  International Association 
of Nonviolent Crisis Intervention program for certified trainer.  Indianapolis, IN. 
Contributing work to grants and proposals 
 State of Indiana Division of Mental Health and Addiction Illness 
Management and Recovery Proposal (2012, funded) 
 SAMHSA Meaningful Use Primary Care Behavioral Healthcare 
Integration Health Information Technology (2011, funded) 
 Center for Medicare Medicaid Services Innovative Healthcare 
Services (2011-2012, unfunded) 
 Substance Abuse and Mental Health Services Administration 
(SAMHSA) Homelessness Grant (2010, unfunded) 
 
 
 
